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ABSTRACT
BIOPHYSICAL AND BIOMOLECULAR COMPONENTS OF DENDRITIC
CELL CHEMOKINESIS ON PDMS SURFACES
Amy C. Bendell
Daniel A. Hammer

Dendritic cells (DCs) are important regulators of the adaptive immune response.
Integral to their antigen-presenting capability is their ability to travel from sites of antigen
capture in peripheral tissues to the T cell rich zones of the lymph node. Along the way,
they encounter many different environments and are presented with a variety of chemical
and biophysical cues. However, the response of DC migration to these extracellular cues
is not fully characterized. My first goal was to establish an in vitro culture system for
studying DC chemokinesis. I chose to use PDMS surfaces due to their biocompatibility
and easy functionalization. I determined that DC chemokinesis is a diffusive process
modeled well by a persistent random walk. In addition, I used micropost array detectors
(mPADs) to quantify the forces of chemokinesis. Next, I sought to identify biophysical
and biomolecular characteristics that contribute to DC chemokinesis. Despite the
diversity of microenvironments that DCs encounter, there is a paucity of information
about how DCs respond to the physical characteristics of their surroundings. I addressed
this question by examining differences in DC migration on surfaces with different
stiffness, 2D geometry and ligand patterning. I show that DCs are insensitive to
differences in substrate stiffness but are sensitive to the spatial organization of ligand. In
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addition, I investigated signaling pathways involved in environmental sensing. To my
knowledge, this is the first investigation of DC response to substrate stiffness and
geometry. Finally, I quantified random motility and force generation in HS1 -/- and
WASP -/- DCs. I determined that both proteins are required for random migration,
through their regulation of cellular speed. In addition, I determined that both proteins are
involved in force generation. This study provides the first description of the influence of
HS1 on DC random migration as well as the first measurements for traction forces from
HS1 and WASP deficient DCs. In this thesis, I build upon the current knowledge of DC
chemokinesis by identifying critical biophysical and biomolecular components.
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CHAPTER 1 : INTRODUCTION

1

MOTIVATION
The immune system is responsible for protecting the body from a variety of
infections and diseases. An important constituent of the immune response is the dendritic
cell (DC). DCs are the most potent antigen presenting cell (APC) in the body, and have
the unique role of linking the innate and adaptive immune responses (1). As immature
cells, they circulate in peripheral tissues searching for signs of infection (2). Upon
encountering a danger signal, DCs capture and process antigen and present peptide
fragments on surface-bound major histocompatibility complexes (3). Antigen capture
coincides with maturation, a series of phenotypical and functional changes, including
down-regulation of endocytosis, increased migration and increased expression of CCR7
and various costimulatory molecules (4). Mature DCs are fully primed to transmit their
antigenic signal to T cells and launch an adaptive immune response (4). Essential to their
role as APCs is their ability to migrate from sites of antigen capture in peripheral tissues
to site of antigen presentation in lymph nodes. As such, understanding all the nuances of
DC migration is extremely important.
While DC chemotaxis and haptotaxis have been studied extensively (some
examples include (5–7)), DC chemokinesis has been an infrequent focus. The canonical
picture of DC migration is that these cells travel up a chemokine gradient towards the
lymph node (2). While this is indeed an important process, DCs also spend time
migrating randomly during various stages of their life cycle, such as before entry into
lymphatic vessels and once they reach the saturated environment of the lymph node (7,8).
The goal of this thesis is to gain a better understanding of DC random migration through
identification of important biophysical and biomolecular parameters
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THESIS ORGANIZATION
This thesis contains six chapters. Chapters 1 and 6 provide an introduction and
conclusion, respectively. Chapter 2 provides detailed background information on
dendritic cells, their role in the immune response and approaches for studying them in
vitro. Chapter 3 lays the groundwork for the characterization of DC chemokinesis and
introduces my analysis methods. In this chapter, I quantify a variety of motility metrics
and traction forces, and highlight the usefulness of PDMS. In the next two chapters, I
explore a variety of biophysical and biomolecular factors that play a role in DC
migration. I first focus on the biophysical aspects of migration and examine the influence
of substrate stiffness and geometry in chapter 4. I then move on to an analysis of two
different cytoskeletal proteins in chapter 5, and how they affect motility and force
production. Collectively, this thesis contributes to the field of DC research by providing
a better understanding of how this unique cell navigates a diverse array of environments
and modulates subcellular signaling along the way.

Specific Aim 1
In this aim I quantify DC chemokinesis on PDMS-coated coverslips. I
hypothesize that DCs will migrate well on these surfaces and that I will find an optimal
fibronectin and chemokine combination for random motility. I quantify DC migration
using a persistent random walk model and measure traction forces using micropost array
detectors (mPADs).
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Specific Aim 2
In this aim, I seek to determine the influence of biophysical parameters on DC
migration. I hypothesize that DC migration will be affected by the physical
characteristics of their microenvironment, such as stiffness and geometry. I perform
further studies to identify the subcellular signaling pathways responsible for interacting
with the external milieu.

Specific Aim 3
In my final aim, I identify two biomolecular components of DC random
migration. I hypothesize that both proteins are required for efficient random motility and
force generation. I perform studies to quantify a variety of motility parameters and
further probe cellular signaling through the use of small molecule inhibitors.

4

CHAPTER 2 : BACKGROUND
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Throughout the next decade, Steinman and others began to characterize the
properties and functions of DCs. It was noted that DCs were a very rare cell type,
constituting up to 1% of nucleated cells in lymphoid organs and barely detectable in
nonlymphoid tissues (1). Through lethal irradiation and reconstitution experiments, it
was shown that DCs originated from precursor cells in the bone marrow, and to a lesser
extent the spleen (2). It was also shown that DCs are loosely adherent, non-proliferating
and viable in cell culture, which helped to pave the way for forty years of in vitro DC
research (3). Towards the end of the 1970s, Steinman showed that DCs are highly potent
stimulators of the mixed leukocyte reaction (MLR); as few as 300-1000 DCs are capable
of inducing a strong response (4). DCs are much more stimulatory than other immune
cell types, and in spite of their low numbers, they are the main cell type responsible for
carrying out the MLR in lymphoid organs (4). Steinman further identified the presence
of major histocompatibility complex (MHC) molecules on all DCs, thus solidifying their
role as a highly potent APC (3). For all this seminal work on DC discovery and
characterization, Ralph Steinman was honored with the 2011 Nobel Prize.

DC Ontogeny and Heterogeneity
DCs can be subdivided into three general classes: classical DCs (cDCs),
Langerhans cells (LCs) and plasmacytoid DCs (pDCs), each with different origins and
specialized functions (5). Common features of all DCs are expression of CD45, MHC
class II and CD11c; absence of lineage markers from T cells, NK cells, B cells,
granulocytes and erythrocytes; presence of transcripts for Flt3, c-kit, CCR7 and the zinc
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finger transcription factor zbtb46 (5). Figure 2.1 provides a summary of the DC subtypes
discussed below.
cDCs develop outside of the bone marrow from circulating, committed pre-cDC
progenitors, and can trace their origin to both common lymphoid progenitors (CLPs) and
common myeloid progenitors (CMPs) (5). cDCs have a short half-life and develop
quickly, with repopulation taking only 2-3 days (6). There are two categories of cDCs—
Batf3-dependent/CD8+ or CD103+ cDCs and Irf4-dependent/CD11b+ cDCs (5,7). Batf3
cDCs can be further subdivided into tissue resident CD8+ DCs and migratory
CD103+langerin+ DCs (5,7). Development of Batf3 cDCs is dependent on Flt3 ligand
and the transcription factors IRF8 and Batf3, and these cells are specialized in cross
presentation (7). Irf4 cDCs can be further subdivided into tissue resident CD8-CD11b+
cDCs and migratory CD11b+ cDCs (5,7). Their development depends on Flt3 ligand and
the transcription factors RelB and IRF4. These cells are specialized for MHC-II
presentation (7).

7

Figure 2.1. DC origin, development and heterogeneity.
Arrows indicate a stage of DC development or migration between tissues. Key
developmental factors for each DC subset are shown adjacent to the arrows. Adapted
from (5).
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LCs were discovered in the epidermis by Paul Langerhans in 1868 (6). The true
character of the LC went unidentified for many years, as it was initially thought to be a
component of the nervous system (with its dendritic morphology resembling that of
neurons) (6). It has since been shown that LCs are a type of DC and share many of the
functions of their cDC counterparts (8). LCs are located in the epidermis and oral and
vaginal mucosa and constitute 3-5% of nucleated cells in these tissues (5,7). Unlike
cDCs, LC development does not depend on circulating precursor cells from the bone
marrow; rather LCs develop from a source of embryonic monocytes that seed the skin
prior to birth (5,6). LC development (repopulation time of several weeks) and turnover
(half-life of 53-78 days) are also much slower than cDCs and are dependent on MCSF-R,
IL-34 and the chemokine receptors CCR2 and CCR6 (6). Finally, LCs contain a
combination of distinguishing features such as high expression of langerin and DEC-205
and the presence of Birbeck granules (6).
pDCs, like LCs, were not immediately recognized as DCs (9). Unlike cDCs, they
fully form in the bone marrow before seeding peripheral tissues (10). They can develop
from either CLPs or CMPs in a process that depends on Flt3 ligand (7,10). pDCs are
most widely known for their ability to recognize and fight viral infections (9). They
achieve this through expression of specific toll-like receptors (TLR7 and TLR9) and
production of high levels of interferons (10). They can further be differentiated from
cDCs by their surface phenotype (CD11b-CD11clowB220+ in mice) (10).
An additional subset known as monoctye-derived DCs or “inflammatory DCs”
develop directly from monocytes in response to active inflammation (7). These DCs
have a phenotype and function similar to cDCs, but are ontogenically distinct and require
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MCSF-R for development (7). The DCs that are discussed in the body of this thesis are
most similar to these monocyte-derived DCs, and were generated by treating
hematopoietic progenitor bone marrow cells with GM-CSF in vitro (11,12). Initially, this
method was believed to generate cDCs, but recent studies have highlighted the unique
nature of GM-CSF DCs (13,14). Further work needs to be performed to fully
characterize this specific DC subset.
The above descriptions pertain to murine DCs, which have been the principal
focus of research on DCs for the past few decades. Characterization of human DCs
lagged behind murine DCs due to the relative difficulty in obtaining adequate numbers of
cells (7). The development of protocols for the generation of DCs from human blood
mononuclear cells has facilitated human DC research (15), and recent advances in
transcriptome analysis have allowed researchers to match homologous murine and human
DCs types (7). The two cDC subsets in humans are BDCA1/CD1c+ and
BDCA3/CD141+, which correspond to murine IRF4/CD11b+ and Batf3/CD103+ cDCs,
respectively (7).

DC Maturation
Dendritic cells exist as a heterogenous population of cells in a variety of
developmental stages. The transition from immature DC to mature DC is accompanied
by a collection of phenotypical and functional changes termed maturation or activation.
The process of maturation can be triggered by a variety of signals, including, but not
limited to, whole pathogens and pathogen-derived molecules (i.e. LPS, CpG, dsRNA),
mechanical stress, exposure to necrotic cells, heat shock proteins, signs of infection (i.e.
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IFN-α, IFN-β, IL-15), degradation of ECM components and CD40 engagement (16–26).
Upon encountering one of these signals, DCs down-regulate immature DC markers (i.e.
CD1a, CD115, mannose receptor), up-regulate MHC class I and II molecules,
costimulatory molecules (i.e. CD80, CD83, CD86, CD40) and adhesion molecules (i.e.
VLA-4, CD54/ICAM-1), and produce a variety of cytokines (i.e. IL-1β, TNF-α, IL-8, IL12, IL-18, IFN- α, IFN-β, IFN-γ, MCP-1, MIP-1α) (18,22,23,27,28). Morphologically,
DCs become more irregularly shaped, with an increasing number of dendrites, long veils
and sheet-like projections (20,24). DCs lose their podosomes and transition from
adherent, tissue-resident cells to highly migratory cells (29,30). Chemokine receptor
expression switches from inflammatory receptors (i.e. CCR1, CCR2, CCR5, CXCR1) to
constitutive receptors (CCR7, CXCR4, CCR4), facilitating the exit of DCs from sites of
inflammation and their entrance into the T cell rich areas of lymph nodes (31). By the
time DCs reach T cell rich areas, they have downregulated their capacity to capture and
process antigen and are capable of stimulating T cells through stable adhesion and
synapse formation (16,22,32).

DENDRITIC CELL FUNCTIONS
Antigen Capture and Processing
Immature dendritic cells use macropinocytosis and receptor-mediated endocytosis
to sample large volumes of soluble and small particulate molecules in their surroundings
in search of danger signals (33). Macropinocytosis and endocytosis are regulated by the
activities of the Rho GTPases Rac1 and cdc42 (34), respectively, and macropinocytosis is
down-regulated upon maturation (33). Dendritic cells are also capable of phagocytosis of
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large pathogens (i.e. apoptotic cells, bacteria and yeast) through the activity of various
phagocytic receptors (i.e. Fcϒ Type I and II, CD36, αvβ5 and VLA-5) (35–38). Unlike
other phagocytes, such as macrophages, DCs are not involved in complete degradation of
pathogens; they have tuned their lysosomal machinery for partial degradation, thus
enabling them to retain antigen peptides for presentation to T cells (39). One method in
which DCs regulate peptide degradation is through control of lysosomal pH (40,41).
Immature DC lysosomes have a weakly acidic pH, which encourages activity of protease
inhibitors, impairs proteolytic degradation and provides a stable environment for antigen
and MHC class II colocalization (40,41) . Upon maturation, the lysosomal pH drops,
which allows for proteolysis and peptide loading onto MHC class II complexes (40,41).
This acidification process is rather slow (~24 hours), allowing for highly coordinated
antigen/MHC class II movement to the plasma membrane and migration to T cell rich
areas of lymph nodes (41).
Another APC function unique to DCs is cross-presentation of exogenous antigens
(i.e. apoptotic cells, pathogens, infected cells or tumor cells) on MHC class I molecules
(42,43). For cross-presentation to occur successfully, exogenously derived antigens must
be partially degraded in endocytic vesicles, exit the endocytic pathway via the cytosol
and transit from the cytosol to the endoplasmic reticulum, where the MHC class I
molecules reside (43,44). This is an energy intensive process and requires the activity of
ATP-dependent translocators (TAP1/2) (44). Once assembled, the peptide/MHC class I
molecules travel via the Golgi to the plasma membrane where they can by recognized by
CD8+ T cells (44). Through these various methods of antigen capture and processing,
DCs are able to colocalize and load antigen peptides onto MHC class I and II molecules
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and provide a potent stimulus for cells of the adaptive immune system, a topic which is
discussed in detail below (35,37).

Activation of CD4+ T cells
Perhaps the most widely studied function of DCs is their ability to activate T
cells. Dendritic cells are the most efficient APC, capable of presenting both endogenous
and exogenous antigens and eliciting a strong T cell responses (45). Through coordinated
random migration and dynamic dendrite extension, DCs actively search for cognate T
cells in the lymph node (46). About 5000 T cells can scan a given DC per hour, allowing
small numbers of DCs to elicit high levels of T cell activation (46). The exact nature of
DC-T cell interactions appears to vary depending on the context. Traditionally, T cell
activation was thought to depend on stable, long-lived interactions with dendritic cells.
Many have shown that DCs and T cells form aggregates in culture (47). T cells and DCs
form stable immunological synapses, consisting of antigen-loaded MHC complex, TCR
and a variety of costimulatory molecules (48). DCs are actively involved in this process,
through polarization of F-actin and fascin at the site of contact; inhibition of the dendritic
cell cytoskeleton leads to their inability to activate T cells (49). DCs can remain tightly
associated with T cells for many hours, leading to T cell activation and clonal expansion
(50). However, it has also been shown that DCs can activate T cells through a series of
successive, short-lived interactions, and it is possible that these interactions lead to a
cumulative activation signal (46,47). Regardless of the exact nature of DC-T cell contact,
a DC is able to provide three distinct activation signals to T cells: peptide-loaded MHC
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complex, costimulatory molecules and soluble cytokines; perturbation of any of these
signals can eliminate or significantly alter the T cell response (51,52).
An emerging area of study is the ability of dendritic cells to shape the specific
type of immune response through TH (T helper) cell polarization. The classical view of
this process is that different subsets of DCs lead to the different types of TH cells. In
mice, CD8α+ DCs lead to TH1 polarization (IL-2 and IFN-ϒ producing T cells, cellmediated adaptive immunity), while CD8α- DCs lead to TH2 polarization (IL-4, IL-5 and
IL-10 producing T cells, humoral adaptive immunity); likewise, in humans, monocytederived DC1 lead to TH1 polarization and DC2 lead to TH2 polarization (53–55). While
this does seem to explain many cases of TH cell polarization, it is not a hard and fast rule
(56). The type of response seems highly dependent on the type of cytokine secreted by a
given DC. CD8α+ DCs or DC1 generally produce high levels of IL-12, which appears to
be critical for TH1 induction; in fact, TH1 responses can be eliminated with IL-12
inhibition or artificially induced by adding exogenous IL-12 to CD8α- DCs or DC2
(54,57). A comparable TH2-specific cytokine has not yet been identified, although IL-4
may play a role (53,55,56). Further confounding the picture are reports suggesting that
the polarization response may be determined as early as DC maturation, with different
maturation stimuli leading to different TH subsets (56). It has also been suggested that
the DC:T cell ratio may affect the type of TH cells formed, and that pre-existing TH cells
can provide negative feedback and regulate DC numbers and priming ability (55,56).
Additionally, DCs can polarize the immune system towards tolerance, through activation
of regulatory T cells, preventing aberrant immune cell function and autoimmunity (58).
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Through these various activities, dendritic cells garner the status of the most potent
antigen-presenting cell in the body.

Activation of CD8+ T cells
DCs not only indirectly activate cell-mediated adaptive immunity through TH1
polarization, but also directly activate this branch of the adaptive immune response
through their interactions with CD8+ T cells. DCs activate the subset of CD8+ cytotoxic
T cells, which are responsible for clearing the body of harmful cells, independently of
CD4+ activity (59,60). DCs regulate CD8+ T cell proliferation and effector function
through regulation of cytokines (i.e. IL-4 and IL-2), presentation of antigens via MHC
class I complexes and direct engagement through costimulatory molecules (60–64).
Through their activation of CD8+ T cells, DCs have been implicated in the ability of the
immune system to combat viral infections (i.e. HSV-1, influenza A), bacterial infections
(i.e. Listeria monocytogenes), parasitic infections (i.e. Plasmodium yoelii) and cancer
(62,65,66).

Activation of B cells
As discussed above, DCs are able to indirectly induce a humoral immune
response through activation of TH2 polarized CD4+ T cells and through the formation of
clusters with cognate T cells and B cells in the lymph node (56,67). They were initially
thought as nothing more than accessory cells, impacting B cell activation indirectly
through the activation of T cells (68). It is now understood that DCs directly interact
with B cells through extensive cell-cell contact (69), presentation of intact antigen in
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membrane bound immune complexes (70) and release of soluble cytokines (71).
Through these physical and chemical cues dendritic cells ensure B cell survival (72),
increase B cell retention in the T cell zone (69), promote B cell proliferation and
differentiation (71) and induce antibody production and class switching (70,73). A more
thorough understanding of the interaction of DCs and B cells may lead to better medical
treatments for diseases such as lupus, in which DCs lead to increased levels of B cell
proliferation (74).

Activation of Natural Killer Cells
While much focus has been placed on the ability of dendritic cells to launch the
adaptive immune response, recent studies have shown that dendritic cells are also able to
enhance the innate immune response through their interaction with natural killer (NK)
cells. Coculture of dendritic cells with natural killer cells leads to increased NK cell
activation, as shown by proliferation and expansion of NK cell populations (75),
increased Ca2+ signaling and IFN-γ secretion (76), upregulation of CD69 (77), de novo
expression of CD25 (78) and increased cytolytic activity (79). Direct DC and NK cell
contact is necessary (77,80,81), and leads to the formation of actin-rich immunological
synapses, enriched in cytosolic cytokines (i.e. IL-12, IL-15) and adhesion molecules (i.e.
LFA-1, talin) (76,77,82,83). Due to the interaction of NK cell inhibitory molecules (i.e.
KIR, CD94) and MHC class I receptors on mature DCs, dendritic cells are able to remain
viable after interacting with NK cells, thus enabling them to launch both an immediate,
innate immune response and a delayed, adaptive immune response (75,77,78) While not
fully understood, many studies have shown reciprocal activation of DCs and NK cells,
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suggesting that feedback loops are in place to amplify specific NK-mediated immune
responses (84). Understanding DC and NK cell interactions will be useful in treating a
variety of diseases, as impaired DC-mediated NK activation leads to greater susceptibility
to infections such as HSV (65) and poorer tumor clearance (85).

DC MIGRATION
Migration is critical for proper antigen presentation. DCs tune their migration to
their maturation state and their stage of antigen presentation (antigen capture vs. active
presentation to T cells) (86). Immature DCs express inflammatory chemokine receptors,
such as CCR1, CCR5 and CCR6, which allow them to home to sites of infection (87,88).
Maturation changes the chemokine receptor expression profile, most notably by downregulating the inflammatory receptors and up-regulating CXCR4 and CCR7 (87,88).
CCR7 is widely regarded as the most important chemokine receptor for DC trafficking,
since absence of CCR7 or its ligands leads to impaired homing of DCs to lymph nodes
(89,90).
CCR7 interacts with two chemokines—CCL19 (MIP-3β, ELC, exodus-3) and
CCL21 (6Ckine, SLC, exodus-2) (88). In mice, there are two different forms of CCL21,
CCL21-Leu and CCL21-Ser, which are expressed in the periphery and lymph nodes,
respectively (86). CCL19 is found in the lymph node and is also involved in paracrine
signaling by mature DCs (86,87,91). While both chemokines interact with CCR7 with
similar kinetics (92), there are several notable differences between them. First, CC21
can be expressed in a surface bound state or a soluble state after cleavage of its Cterminus, whereas CCL19 only exists in a soluble form (91,93). CCR7 is rapidly
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internalized after binding to CCL19 but not when binding to CCL21, thus leading to
receptor desensitization after CCL19 interactions (94). Binding of CCL21 or CCL19 also
leads to different downstream signaling; binding of surface bound CCL21 has been
shown to regulate integrin-dependent adhesion, polarization and migration, whereas
binding of CCL19 has been shown to regulate filopodial extensions and spreading
(93,95).
The type of migration employed by DCs is highly dependent on the presentation
mode of chemical signals. When DCs encounter a uniform solution of CCL19 or CCL21,
they migrate randomly with increased velocity in a process known as chemokinesis (96).
When DCs encounter a gradient of soluble CCL19 or CCL21, they migrate in a
directional manner in a process known as chemotaxis (96). Similarly, when DCs are
exposed to uniformly printed CCL21, they undergo random migration or haptokinesis,
and when DCs are exposed to a gradient of printed CCL21, they undergo directed
migration or haptotaxis (93). DCs are exposed to a complex array of these signals in the
body and must properly interpret them to home to the T-cell rich areas of lymph nodes
(97). For example, when DCs exit peripheral tissues and enter the lymphatic system,
they need to move directionally toward lymphatic vessels, following gradients of soluble
CCL19 and printed CCL21 on the vessel walls (97). At the start of this process, DCs can
detect chemokine signals from adjacent vessels, migrating randomly between the vessels
until they interpret and commit to a single source (97). Once in the lymph node,
chemokine signals become saturated and DCs begin to migrate randomly, dancing around
in search of cognate T cells (46,64). An overview of the canonical DC migration
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process—from antigen capture in the periphery to T cell homing in the lymph node—is
shown in Figure 2.2.
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Figure 2.2. Overview of DC migration from peripheral tissues to the lymph node.
Circulating DC precursors exit the bloodstream and populate bronchial tissue. Upon
antigen capture, DCs upregulate CCR7 and follow gradients of CCL19 and CCL21 to the
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lymph node. Adapted by permission from Macmillan Publishers Ltd: [Nat Rev
Immunol] (89), copyright (2008).
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The exact response of DCs to competing chemokine signals is still under
investigation. In 2D systems, it has been shown that soluble CCL19 is more potent than
soluble CCL21 and that DCs in counter gradients home to a location where the two
signals are balanced, displaying random migration in the region where the competing
gradients are balanced (92). In contrast, when DCs are exposed to counter-gradients of
CCL19 and CCL21 in 3D, CCL21 seems to provide a more potent signal (91). The fact
that results in 2D and 3D seem to contradict each other can be reconciled given how
different the mechanisms of DC migration are in 2D and 3D (98). In 2D, DC migration
is integrin dependent, while in 3D, DCs are able to migrate in an integrin-independent
fashion (98). A firm understanding of DC migration in both 2D and 3D is critical. In the
following chapters, I have added to the current knowledge, with descriptions of DC
chemokinesis and how it is affected by various cytoskeletal proteins and signaling
pathways as well as physical characteristics of the environment.

DENDRITIC CELLS AND DISEASE
Defects in DC function have been shown to contribute to a variety of diseases. As
a result, many groups have started to explore the power of harnessing DCs for
immunotherapy treatments. Two of the most widely researched diseases for DC
immunotherapies are cancer and HIV.

Cancer
Cancer is able to evade the immune system by rendering it ignorant and tolerant
(99). Much of the impact cancer has on the immune system is mediated by its effects on
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DC function (99). Tumors secrete a variety of soluble factors (i.e. VEGF, M-CSF, IL-6
spermine, IL-10, tumor-derived gangliosides, prostaglandin E2) that inhibit DC
development from CD34+ hematopoietic progenitor cells and lead to an accumulation of
myeloid precursors in the blood (99,100). In addition to reducing DC development,
many of these factors also lead to apoptosis of circulating DCs (101). Collectively this
leads to lower numbers of DCs in the peripheral blood of cancer patients (100). Of the
DCs that successfully develop and avoid premature death, many are functionally
impaired through perturbations in their maturation state (99). DCs in cancer patients
express increased levels of the maturation marker CD83 and are inefficient at antigen
capture (100). These DCs are further characterized by reduced expression of MHC class
II, CD86 and CD40 and decreased production of cytokines such as IL-12 (100,102).
Collectively this leads to DCs that mature prematurely and incompletely, fail to capture
tumor antigens, are unsuccessful at activating anti-tumor T cell responses and induce
immune tolerance (99,102).
Improving DC function in cancer patients could improve the ability of the body to
fight off the disease. Many early studies showed that ex vivo generated DCs primed with
tumor antigen in vitro were able to induce potent anti-tumor T cell responses when
injected back into the host (103). DC cancer research has now progressed to numerous
clinical trials in human subjects (104). DC cancer vaccines are considered safe and have
minimal side effects (104). One DC immunotherapy, PROVENGE® (Dendreon
Corporation; Seattle, WA), has already been approved by the FDA for the treatment of
hormone-refractory prostate cancer and has been shown to significantly increase patient
survival time (104). In spite of the strong protective immune response imparted by DC
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cancer vaccines, migration of ex vivo generated DCs remains rather inefficient, with less
than 5% of intradermally injected DCs reaching draining lymph nodes (105). Efforts to
improve DC trafficking are ongoing and have included pretreatment of the vaccine
injection site with inflammatory cytokines or toll-like receptor ligands and investigations
into different modes of delivery (i.e. intravenous, sub-cutaneous, intra-dermal) (105,106).
Understanding DC migration is critical to the improvement DC cancer vaccines.

HIV
Another major illness that is able to evade the immune system through
manipulation of DCs is HIV (107). HIV proteins readily bind to DC receptors such as
DC-SIGN (108). Despite this binding affinity, the virus does not rapidly replicate within
DCs; rather DCs act as carriers which efficiently spread the virus to CD4+ T cells (107).
HIV binding to DC receptors leads to activation of cdc42 and the formation of large
numbers of membrane extensions (108,109). This hijacking of the DC cell membrane
allows for extensive contact between DCs and target T cells, the formation of an
infectious synapse and transfer of HIV proteins (108,109). It has also been shown that
DCs from HIV patients are less efficient at stimulating protective T cell responses and
often induce tolerance (107).
Collectively, this makes DCs prime targets for HIV vaccines. Both immature and
mature DCs are capable of trans-infecting T cells, but only mature DCs are able of
eliciting a potent CD4+ T cell response (108–110). To ensure immunity and not
tolerance, maturation stimuli need to be added prior to administration (110). Early DC
HIV vaccines employed ex vivo generated DCs pulsed with heat-inactivated HIV (111).
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These clinical trials were safe, led to significant reductions in viral load and resulted in
significant increases in HIV-1 specific CD4+ T cell responses for up to a year postvaccination (111). Another promising avenue for HIV vaccines is the use of DC-targeted
antibodies conjugated with HIV gag proteins (110). Preliminary studies in mice have
shown that this method is more effective than other vaccination methods and could
provide long-term, broad spectrum, systemic protection against HIV infection (110).

METHODS OF IN VITRO DC CHARACTERIZATION
DC Sources for In Vitro Study
Historically, DCs and DC precursors have been obtained from a variety of sources
for in vitro studies, including the spleen (112), heart and kidney (113), thymus (114),
fetal skin cells (115), whole blood (15,116) and bone marrow (117). Thanks to advances
in in vitro culture methods, large populations of highly purified DCs can be generated.
Today, the most common sources in humans and mice are peripheral blood mononuclear
cells (PBMNCs) obtained from the blood and bone marrow progenitors obtained from
femurs and tibia, respectively. Critical factors for the in vitro development of DCs
include the cytokine GM-CSF, fetal bovine serum (118) and culture dish type and ECM
composition (119,120). Additional factors that may enhance DC generation include IL-3,
IL-4, IL-7, Flt-3-L, TNF-α, IL-1β, SCF, CSF-1, CD40-L, TGF-β1, although their
importance and the nature of their effect on in vitro DC generation is still a matter for
debate (114,121–124). Some groups have started to translate these in vitro studies into
methods for enhancing DC generation in situ. For example, Maraskovsky et al. have
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shown that injection of Flt 3-ligand into healthy human volunteers leads to an increase in
DC levels, a result that could be useful in augmenting the natural immune response (125).

Polydimethylsiloxane
Traditionally, 2D migration has been studied on glass and tissue culture plastic
surfaces. While these surfaces have been very useful in basic characterization of cell
behavior, they are not very versatile and have little physiological relevance (i.e. very stiff
compared to most tissues) (126). An alternative material for use in cell culture is PDMS
(polydimethylsiloxane). PDMS is a silicon-based polymer consisting of methyl groups
along a siloxane backbone (127,128). PDMS has many favorable qualities for use in
biological research; it is chemical inert, thermally stable, durable, permeable to gases,
easy to use, inexpensive, transparent, non-fluorescent and nontoxic (128,129). It is
highly biocompatible and is already in use for many medical devices, such as catheters,
pacemakers and ear and nose implants (128). PDMS substrates are made by mixing
polymer base and cross linker, with the stiffness depending on the ratio of the two
components (increase in cross linker leads to decrease in stiffness) (128). The
recommended ratio for most applications is 10:1 and this can be spun onto glass
coverslips and other surfaces to provide thin and uniform substrates for cell migration
(128).

Soft Lithography
The use of PDMS to make cellular substrates is known as soft lithography, and
was developed in 1993 by Whitesides et al., as an alternative for photolithography (129).
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Photolithography has been in use in the semi-conductor industry since the late 1950’s, but
poses many challenges for biological applications (127). It is complex and expensive, it
uses harsh solvents, it is limited to planar surfaces, it does not integrate well with other
cell culture materials and it provides little control over the chemistry of surface patterning
(127,129). For these reasons, soft lithography has replaced photolithography in many
cellular applications.
One of the most widely used soft lithography techniques is microcontact printing,
which is used to precisely and gently transfer biologically active proteins to surfaces
(129,130). The method involves inking an elastomeric stamp with a protein solution,
gently rinsing and drying the stamp and finally transferring the protein monolayer on the
stamp to a target substrate through conformal contact (130). Microcontact printing is fast
and efficient, and can be used to make patterns on a variety of different materials, such as
glass and PDMS (130).
When using PDMS surfaces, it is important to properly treat the substrate prior to
printing (131). PDMS is innately hydrophobic due to the presence of methyl groups,
which prevents the transfer of protein during stamping (131,132). Treatment of PDMS
with UV ozone makes the surface hydrophilic through the replacement of methyl groups
with SiOH groups (128,132). This is a transient process, with significant hydrophobic
recovery occurring after exposure to air for 30 minutes (128). Once PDMS surfaces are
treated with UV ozone, protein is rapidly and preferentially transferred from the stamp
(133,134).
Microcontact printing can be used to create a variety of adhesive patterns with
micron-sized features (131). Printing small features initially posed problems due to
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stamp compliance and collapse (127). This problem is resolved by either coating the top
of the stamp with a stiff polymer or by using the stamp off method (which involves
making the desired pattern with a planar stamp) (131). Microcontact printed surfaces are
often blocked to restrict cell engagement to the printed areas and eliminate nonspecific
interactions with the underlying substrate (134). Overall, microcontact printing has
proven to be a useful tool for investigating the importance of adhesive signals on
processes such as cell shape and migration (131,135).
Another soft lithography method that is very useful for the study of cell migration
is replica molding (129). Replica molding involves curing PDMS against a silicon mold
and provides a reliable and repeatable method for duplicating complex micron-sized
structures (129,130). An example of a replica-molded structure is the micropost array
detector (mPAD), shown in Figure 2.3 (136). mPADs are arrays of micron-sized pillars
that are used to quantify cellular traction forces (136). They are an attractive alternative
to bead-containing hydrogels for traction force microscopy (137), as they are both
manufacturally and computationally simple to use and are able to resolve very small
forces (138). Forces are readily calculated from post deflections using beam bending
theory and a known spring constant for the given array (139). The post dimensions (and
consequent geometry and compliance) can be modified to optimize the array for a variety
of cell types (140). Both of the soft lithography techniques discussed above have been
indispensable for my study of DC migration in 2D.
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Figure 2.3. mPAD replica molding.
mPADs are tools used for measuring cellular traction forces and were made possible by
advances in soft lithography. A) Cells engage mPADs and deflect posts. Post deflections
29

can be computed using beam bending theory and the known elasticity (E), moment of
inertia (I) and height (L). B) Schematic of mPAD fabrication. Adapted from (136).
Copyright 2003 National Academy of Sciences.
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CHAPTER 3 : CHARACTERIZING DC RANDOM
MIGRATION ON PDMS SURFACES
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ABSTRACT
Previous studies of DC chemokinesis were performed on glass surfaces
physisorbed with either collagen or fibronectin (1). While glass and plastic tissue culture
surfaces have been very useful in initial characterization of many cell types, they are not
physiologically relevant and are much less versatile than PDMS. I have used a system
consisting of PDMS spin-coated coverslips microcontact printed with fibronectin to
characterize DC random migration. This setup allows us to expose DCs to a surface with
more relevant compliance and to spatially regulate ligand presentation with great
precision. I assayed a variety of fibronectin concentrations and found that while DCs
require the presence of fibronectin on the surface to adhere and migrate, they are
insensitive to the specific concentration of ligand. Likewise, they migrate robustly in the
presence of chemokine, regardless of the concentration present. At each of the ligand and
chemokine concentrations tested, I quantified migration in terms of average speed,
persistence and the random motility coefficient. In addition to these motility
measurements, I used PDMS structures known as mPADs (micropost array detectors) to
measure the traction forces of DCs. Collectively, these measurements provide a
fundamental understanding of DC chemokinesis on PDMS substrates as well as a basis
for comparison in future in-depth studies.
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INTRODUCTION
DCs are critical components of the immune system, responsible for recognizing
pathogenic agents in the body and transmitting signals of the infection to T cells in
secondary lymphoid organs (2). In order for effective antigen presentation to occur, DCs
must be able to travel from sites of antigen detection to T-cell rich areas of the lymph
node (3). Along the way, they encounter many different environments and employ many
different modes of migration. In this and subsequent chapters, I investigate DC
chemokinesis, or random migration in the absence of any chemical gradients. While
chemotaxis, or directed migration, is important for guiding DCs from peripheral tissues to
the lymph node, DC chemokinesis has been observed in the lymph node itself (3–5).
In my experiments, I use fibronectin, which is a ubiquitously expressed
extracellular matrix (ECM) protein, found in many environments encountered by DCs,
including the lymph node (6). While it has been shown that DCs can migrate in the
absence of integrins in 3D, integrin-mediated adhesion to the ECM is required for
migration in 2D (7). Bone marrow-derived DCs (BMDCs) express high levels of α5β1
and can readily bind to fibronectin, thus making it a good choice for studying DCs in
vitro (1,7). 2D migration is often thought to have little physiologic relevance, but certain
environments in vivo promote this crawling type of migration over integrin-independent,
3D swimming (8). For example, it is believed that once DCs reach the lymph node, they
adhere and migrate along the reticular network in their search of T cells (8).
In addition, my experimental setup allows us to study DCs in an environment with
a more physiologically relevant stiffness. AFM measurements of my surfaces indicate
that the spun layer of PDMS is on the order of 102 kPa. The compliance of healthy
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lymph nodes is on the order of 10 kPa (9). While my substrates are still an order of
magnitude stiffer than lymph nodes, they provide a much closer approximation to the
DCs’ native environment than glass or plastic surfaces, which are on the order of 106 kPa
(10). Taken together, I believe that characterizing the random migration of mature DCs
on PDMS-coated coverslips that have been microcontact printed with fibronectin, will
provide a useful and relevant set of information about how DCs might behave in vivo
once they reach the lymph node.
In this chapter, I provide a description of the methods used to quantify DC
random migration. I begin by assaying a variety of fibronectin and chemokine
concentrations in order to determine the optimal parameters for DC chemokinesis. At
each set of conditions, I used a persistent random walk model to calculate average speed,
persistence and the random motility coefficient. I conclude that while the presence of
fibronectin is required for cell adhesion to the substrate, the precise concentration of
fibronectin and chemokine does not greatly influence migration. In addition, I used
mPADs to resolve and quantify the low magnitude traction forces exerted by migrating
DCs. The combination of these measurements provides a thorough biophysical
description of DC random migration.
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MATERIALS AND METHODS
Mice
C57BL/6J mice from Jackson Laboratories were housed under pathogen-free
conditions in the Children’s Hospital of Philadelphia animal facility. All studies
involving animals were reviewed and approved by the Children’s Hospital of
Philadelphia Institutional Animal Care and Use Committee.

Generation of Primary BMDCs
DCs were generated from murine bone marrow following the protocol of Sixt and
Lammermann (11). Mice were euthanized with CO2 and cervical dislocation. Femurs
and tibias were removed and flushed with sterile PBS. Cells were spun for 10 minutes at
1500 rpm and 4°C and resuspended at 2.5 x 106 cells/mL in R10 media (RPMI 1640
supplemented with 10% FBS and 1% penicillin-streptomycin). Cultures were started in
10 cm Bacterial Petri dishes by combining 1 mL of cell suspension, 9 mL R10 and 100
μL GM-CSF. On day 3, 10 mL fresh media and 100 μL GM-CSF were added to each
Petri dish. On day 6, 10 mL of spent media was gently removed from each dish before
adding 10 mL fresh media and 100 μL GM-CSF. On day 7 or 8, DCs were spun for 10
minutes at 1500 rpm and 4°C, resuspended in 10 mL R10 per plate and added to 6 cm TC
dishes along with 200 ng/mL LPS. After 24 hours, DCs were centrifuged for 10 minutes
at 1500 rpm and 4°C, and resuspended at 100,000 cells/mL. Cells were maintained at
37°C and 5% CO2 throughout the entire culture period.
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Preparation of Migration Surfaces
My standard migration surfaces consisted of glass coverslips spun with PDMS,
stamped with fibronectin and adhered to the bottom of a 6 well or 1 well dish. First, a
10:1 solution (base:cure by weight) of PDMS was mixed and degassed. 25 mm round
glass coverslips were cleaned of debris with N2 gas. A thin layer of PDMS was evenly
spun on the surface of the coverslip using a Laurell spinner (4000 rpm, 1 minute). Spincoated coverslips were baked overnight at 65°C. Spun coverslips were fixed to the
bottom of laser-cut wells with a thin layer of PDMS and cured for 1 hour at 65°C.
Fibronectin was transferred to the PDMS-coated coverslips through microcontact
printing. 66 grams of 10:1 PDMS (base: cure, by weight) was mixed and degassed for 1
hour. It was then cast against a clean, flat silicon wafer and baked at 65°C overnight.
The following day, the PDMS was carefully pulled away from the wafer and cut into 1
cm2 stamps. Stamps were sonicated for 5 minutes in 200 proof ethanol to clean the
surface. The clean stamps were rinsed 2x in diH20, dried with N2 gas and inked with a
solution of fibronectin (Sigma-Aldrich), ranging from 1 μg/mL to 100 μg/mL. The inked
stamps were incubated for 2 hours, gently rinsed 2x in diH20 and gently dried with N2
gas. The PDMS-coated coverslips were treated with UV ozone for 7 minutes.
Fibronectin was printed on the treated coverslips by bringing the stamp into contact with
the coverslip surface. The coverslips were blocked with Pluronic F127 for 1 hour at
room temperature, rinsed 2x with sterile PBS and stored at 4°C overnight.
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Random Migration Assays
Mature DCs in RPMI, at a concentration of 100,000 cells/mL were added to the
PDMS-coated coverslips along with the desired chemokine. After a brief incubation to
allow the cells to adhere to the surface, the plate was moved to a Nikon Eclipse TE300
(Nikon, Melville, NY). DCs were imaged at 10x by phase microscopy using custombuilt Labview (National Instruments, Austin, TX) software. A motorized stage was used
to capture images at multiple positions. Images were collected every 2 minutes over a
period of 2 hours. Cells were maintained at 37°C and 5% CO2 for the duration of the
experiments.
Image sequences were opened in ImageJ (NIH; http://rsbweb.nih.gov/ij) and the
Manual Tracking plugin was used to track cell position over time. Cells that were
apoptotic or completely stationary were excluded, as well as any cells in contact with
other cells. I imported the file containing cell tracks to MATLAB (Mathworks, Natick,
MA) and used a custom-written code to calculate the MSD. The Dunn equation
〈

〉=2

−
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−

was used to fit speed (S) and

persistence (P) to the MSD (12). The random motility coefficient was calculated from
the speed and persistence as follows:

=

, where n specifies the dimensionality

(12).

Fabrication of mPADs
mPADs were created by replica molding of PDMS. Patterned silicon masters
were kindly provided by Christopher Chen and were coated with silane by vapor
deposition in a vacuum chamber. Negative molds were created by casting 22 grams of
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degassed 10:1 PDMS (base: cure by weight) against the silicon mold and curing for 12
minutes at 110°C. The molds were carefully pulled away from the master, plasma etched
for 7 seconds and silanized overnight. 2 grams of 10:1 PDMS (base:cure, by weight) was
degassed and cast against the silanized negative molds and degassed for a further 30
minutes. 25 mm glass coverslips were cleaned with N2 gas and plasma treated for 90
seconds. The PDMS-coated molds were adhered to the glass coverslips and cured at 110
°C for 20 hours. The mPADs were removed from the oven, cooled to room temperature
and gently peeled from the molds. They were then sonicated in 200 proof ethanol and
supercritical dried.
mPAD-coated coverslips were fixed to the bottom of one well dishes with a thin
layer of PDMS and cured for an hour at 65°C. Fibronectin was added to the post tips by
microcontact printing as described above, with minor modifications. After gently
stamping fibronectin onto the post tips, 1.4 mL of 200 proof ethanol was added to the
mPAD and the stamp was gently flicked away. The ethanol was immediately diluted by
adding 1 mL of diH2O, and the mPAD was gently rinsed 3x with diH20, being careful not
to completely dewet the surface. The mPADs were incubated with 1 mL of 1x Δ9-DiI
(1,1′-dioleyl-3,3,3′,3′-tetramethylindocarbocyanine methanesulfonate; Invitrogen
Carlsbad, CA) for one hour, at room temperature. From this point onwards, I minimized
mPAD exposure to light. The dye was removed, the mPAD was washed 3x with diH2O
and it was blocked with Pluronic F127 for 1 hour at room temperature. The mPAD was
rinsed 3x with diH20 and stored at 4°C overnight.
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Force Measurement Assays
Mature DCs, at a concentration of 50,000 cells/mL in RPMI were added to the
mPAD substrate along with the desired chemokine. They were incubated briefly to allow
for cell adhesion prior to imaging. Samples were imaged at 40x by phase and
fluorescence microscopy on a Nikon Eclipse TE300 Microscope (Nikon, Melville, NY)
with custom-built Labview (National Instruments, Austin, TX) software. A motorized
stage was used to capture images every 2 minutes for 30 minutes at multiple positions.
Cells were maintained at 37°C and 5% CO2 throughout the duration of the experiment
and light exposure was minimized.
Images were imported into MATLAB and a custom-written script was used to
compute traction forces. Phase images were used to identify the position of DCs and
fluorescent images were used to identify the position of post tips. Deflections from the
ideal, hexagonally packed array, were detected and converted into traction forces using
Hooke’s Law ( =

) and the spring constant of the micropost array (k=1.92 nN/μm).

These forces were then used to calculate the total scalar force per cell.
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RESULTS
Quantification of Chemokinesis
I began by quantifying DC random migration under a variety of fibronectin and
chemokine concentrations. The KD of CCR7 for both CCL19 and CCL21 is ~10 nM
(13). In my initial experiments, I explored three different chemokine conditions—
CCL19 alone, CCL21 alone or no chemokine. I held the level of chemokine constant, at
a concentration of twice the KD, which I hypothesized would be close to the optimal
concentration. At each of these chemokine conditions, I varied the fibronectin inking
concentration over the range of 0.1 μg/mL to 100 μg/mL. As a first step of my analysis, I
used the Manual Tracking plug-in from ImageJ to track cell position over time. Figure
3.1A and B show a sample population of DCs and their corresponding trajectories. All
trajectories are pseudo-centered at the origin and emanate randomly from the center.
There is no directional preference, as one would expect with uniform chemoattractant.
I then used these tracks to compute the mean squared displacement (MSD) as a
function of time. When plotted on a log-log scale, the slope of the MSD curve gives a
semi-quantitative description of the type of migration. If the slope is less than one,
migration is in the subdiffusive regime; if the slope is greater than 1, migration is in the
superdiffusive regime; and if the slope is equal to 1, migration is in the diffusive regime.
For this sample population of randomly migrating DCs, the MSD curve has a slope of
approximately 1, confirming that DCs migrate diffusively or randomly, during
chemokinesis (Figure 3.1C).
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Figure 3.1. Dendritic cells migrate randomly during chemokinesis.
A) Sample phase contrast image of mDCs on PDMS-coated coverslips printed with 1
μg/mL fibronectin. The cells have also been exposed to 20 nM CCL19. Scale bar
represents 100 μm. B) Cell trajectories for mature DCs shown in A). C) Mean squared
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displacement vs. time for the randomly migrating DCs shown in A). Both axes are on a
log scale and the slope is approximately equal to 1.

65

As a final step of the analysis, I fit the MSD to the Dunn Equation (Equation 3.1),
which is a model for persistent random walks (12). This allowed us to calculate a variety
of useful motility metrics, including average cell speed (S) and persistence time (P;
length of time a cell moves in one direction before changing directions). I then used
speed and persistence time to calculate persistence length (PL; the distance traveled
before changing directions; Equation 3.2) and the random motility coefficient (μ; a
measure of cell diffusivity; Equation 3.3). In these equations, n refers to dimensionality,
which in my case is 2.

〈

〉=2
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Equation 3.1
=
Equation 3.2
=
Equation 3.3

Figure 3.2 shows the results from these calculations. For optimization purposes, I
focused on average speed (Figure 3.2A) and the random motility coefficient (Figure
3.2D), since these give a description of how quickly the cells move and the area swept
out by the DCs during chemokinesis, respectively. The presence of chemokine did not
affect DC migration at most printed concentrations of fibronectin, although it did impart a
significant increase in diffusivity at 10 μg/mL of fibronectin (Figure 3.2D). There was no
clear optimal concentration of fibronectin for DC chemokinesis in this range. Despite the
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lack of a clear preference for the level of fibronectin, I determined that lowering the level
of fibronectin below this range prohibited DC adhesion and migration (data not shown).
Collectively, this suggests that during 2D chemokinesis, DCs require the presence of
ECM protein and are able to adapt their migration to a variety of concentrations.
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Figure 3.2. Quantification of DC chemokinesis as a function of fibronectin concentration.
A) Average speed, B) persistence time, C) persistence length and D) random motility
coefficient. Concentration of CCL19 and CCL21 was 20 nM. Figures represent average
values ± SEM, for > 75 DCs from at least three independent experiments per condition.
Statistical significance calculated with single factor ANOVA and post hoc Tukey test. *
indicates significant difference compared to No Chemokine condition. *p<0.05
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I next varied the concentrations of CCL19 and CCL21 over the range of 0 to 100
nM. As I saw with the response to varying surface ligand, variations in soluble
chemokine had little effect on DC migration (Figure 3.3). Because DCs migrated well
even in the absence of chemokine, I considered the possibility that serum in the media
was saturating soluble cues. I tested three conditions, in which DCs were deprived of
serum for different amounts of time—serum deprived immediately before running the
experiment, 3.5 hour serum starve and 24 hour serum starve. When DCs were deprived
of serum for any length of time, their migration was almost completely abrogated. As a
result, I continued to use serum in all future experiments.
Despite finding no significant optimal conditions for fibronectin concentration or
chemokine concentration, I did show that mature DCs migrate well on microcontact
printed PDMS surfaces. Moving forward I chose one set of conditions (10 nM CCL19
and 10 μg/mL fibronectin), for consistency. Table 3.1 shows the values for average
speed, persistence time, persistence length and random motility coefficient at these
conditions.
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Figure 3.3. Quantification of DC chemokinesis as a function of chemokine concentration.
A) Average speed and B) the random motility coefficient. Figures represent average
values ± SEM, for > 300 DCs from at least three experiments per condition.

70

Table 3.1. Values for DC chemokinesis parameters at 10 μg/mL fibronectin and 10 nM
CCL19.
Parameter

Average Value

Average Speed, μm/min

4.00 ± 0.18

Persistence Time, min

4.88 ± 0.46

Persistence Length, μm

19.00 ± 1.57

Random Motility Coefficient, μm2/min

38.20 ± 3.41
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Quantification of Traction Forces
I also measured traction forces during my initial analysis of DC chemokinesis.
mPADs are the best technology available for resolving the small forces exerted by DCs.
DC forces during chemotaxis have been previously characterized (14) and I now sought
to characterize DC forces of chemokinesis. Randomly migrating DCs are able to adhere
to and engage with the micropost tips. For my force measurement experiments I gather
two sets of images—phase and fluorescence. A sample of each is shown in Figure 3.4.
Post deflections can be readily observed at the periphery of the cell. I converted these
post deflections into traction forces and visualized the distribution of forces as a series of
vectors overlaid on the appropriate engaged micropost (Figure 3.4C). The sample cell
shown in Figure 3.4A exerted strong, tugging forces at the periphery, pulling microposts
in towards its center. This is shown by the distribution of relatively large, radially
oriented vectors in Figure 3.4C.
After computing the traction forces of many DCs, I computed the total scalar
force magnitude as a function of time (Figure 3.4D). While the vector forces of any
given cell should sum to zero, the scalar force magnitude is a nonzero, positive value and
provides an idea of the overall strength of DC interactions with their substrate. I began
taking measurements of forces 15 minutes after addition of DCs to the mPAD, allowing
them time to adhere to the microposts tips. Time zero in Figure 3.4D corresponds to the
first minute of imaging and laser exposure. At early imaging timepoints, I see an
increase in force. This initial rise is followed by a force plateau, although even during the
“plateau” regime there is a fair bit of fluctuation. Finally, I computed a time and
ensemble average of force per cell. Mature DCs migrating randomly on mPADs generate
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a total force of 13.76 ± 0.84 nN. This value is the same order of magnitude as the
previously reported value for DC force generation during chemotaxis (14).
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Figure 3.4. Quantification of DC traction forces during chemokinesis.
A) Sample phase and B) fluorescent images of a DC on an mPAD printed with 10 μg/mL
fibonectin. 10 nM soluble CCL19 was also present. Scale bar represents 20 μm. Post
deflections from B) were used to calculate the vector force per post and scalar force
magnitude. C) Vector forces produced by the cell shown in A). D) Average traction
force as a function of time. The values correspond to the total scalar force magnitude of
29 mature DCs from 3 independent experiments.

74

DISCUSSION
The results from this chapter lay the groundwork for my future studies into the
biomolecular and biophysical aspects of DC chemokinesis. I selected a set of standard
conditions and quantified the speed, persistence and random motility at these conditions.
While it may seem counterintuitive that DCs do not respond to fibronectin or chemokines
in a biphasic manner, this finding is consistent with previous studies of DCs on glass (1).
DCs did respond in a biphasic manner when migrating on collagen, but were
unresponsive to differences in concentration on fibronectin (1). This suggests that when
studying DC migration, observations might be ligand specific. Attempts to optimize
migration by varying the chemokine concentration or removing serum from the solution
were unsuccessful. These observations are supported by a recent study by Haessler et al.,
who compared potencies of CCL19 and CCL21 for DC migration and observed that
while both induced very strong chemotaxis, they had little influence in chemokinesis
(15).
Overall my quantification of DC random migration on PDMS-coated coverslips
fits well with a model for persistent random walk. The slope of the MSD versus time is a
linear, with a slope approximately equal to one, indicating pure diffusion. In addition, it
has been shown that the speed and persistence time of randomly migrating cells are
inversely correlated (Figure 3.5; (16)). My results also follow this relationship (16).
Furthermore, the value I calculated for average cell speed agrees well with a variety of in
vitro and in vivo measurements (7,17). While DC speed appears to be very robust across
a variety of environments, persistence time for DCs in different environments is not well
characterized and will be a topic of discussion in the next chapter. Taken together, I
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conclude that PDMS-coated coverslips are excellent surfaces to use in the study of DC
chemokinesis.
My traction force analysis confirmed the usefulness of mPADs for measuring DC
traction forces. In my experiments, I exposed DCs to a uniform concentration of
chemokine, whereas previous measurements were made for DCs exposed to a gradient of
chemokine (14).
In addition, while fibronectin was printed on the micropost tips in both sets of
experiments, the concentration was 5-fold less in my studies. In spite of these
differences, I see similar levels of forces generated. DCs during chemokinesis generate
13.76 ± 0.84 nN per cell, whereas DCs during chemotaxis generate 18 ± 1.4 nN/cell (14).
It has been shown that DCs migrating up a gradient concentrate strong traction forces at
the leading edge (14). Because I studied random motility, in which there is no persistent
leading edge, this observation was not as apparent. Further analysis could be performed
to correlate force distribution and direction of migration. Collectively, my experiments
quantifying random migration parameters and traction forces provides a clear description
of how DCs behave during chemokinesis, and lays the groundwork for the results
presented in the next two chapters.
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ABSTRACT
Dendritic cell (DC) migration is required for efficient presentation of antigen to T
cells and the initiation of an adaptive immune response. In spite of the importance of
migration for DC function, many aspects of its migration have not yet been characterized.
One question in particular that remains unanswered is how DCs respond to differences in
their microenvironment. I have previously quantified DC migration on
polydimethylsiloxane (PDMS)-coated glass coverslips and measured DC traction forces
on micropost array detectors (mPADs) made from PDMS. mPADs differ from spincoated PDMS in both stiffness and geometry. Since DCs encounter a variety of
environments with different stiffness and geometry, but the effect of these parameters on
DC migration has not yet been determined, I sought to address this question. I found that
DCs migrate well on mPADs printed with fibronectin, with a significant increase in
average speed and a significant decrease in persistence time as compared to spin-coated
PDMS. To determine whether the geometry or compliance of the post arrays was
responsible for these changes in DC migration, I quantified DC migration using several
different mPAD geometries. For mPADs with the same geometry but a different stiffness,
migration was indistinguishable, indicating that DCs are insensitive to changes in
stiffness over the range tested (~1 kPa to 1000 kPa). I tested an additional mPAD with
smaller post diameter to determine how sensitive DCs are to post geometry and
determined that DCs cannot sense differences in geometry on the micron scale. I further
investigated geometry sensing by printing ligands on PDMS-coated coverslips in patterns
resembling the geometrical pattern of the tips of mPADs, and determined that the DC
response to geometry is due to ligand patterning. Indeed the response was
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indistinguishable between printed continuous surfaces and on mPAD arrays. Finally, I
used a variety of small molecule inhibitors to determine what pathways are involved in
the motile response of DCs to geometry. I saw significant effects in the ability of DCs to
sense geometry when I inhibited myosin contractility with blebbistatin and when I
blocked adhesion through the integrin α5β1. I also noted significant reorganization of the
actin cytoskeleton into dynamic actin rings when DCs were motile on posts. From these
experiments, I conclude that DCs are insensitive to substrate compliance but respond to
changes in geometry via a mechanism that involves integrin function, myosin
contractility, and the remodeling of the actin cytoskeleton.
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INTRODUCTION
Dendritic cells (DCs) are antigen presenting cells, capable of activating naive T
cells and launching potent adaptive immune responses (1). As immature cells, DCs are
distributed throughout peripheral tissues, where they continuously capture and degrade
material from the environment, displaying peptide fragments on surface-bound MHC
complexes. When DCs detect molecular signs of infection and inflammation (2), they
undergo a series of phenotypic and functional changes, a process termed maturation (3).
Mature DCs become highly migratory and travel to T cell-rich areas of lymphoid tissues
where they present surface bound antigens to T cells and activate them (4). DC migration
is therefore critical to the ability of the body to launch a proper immune response.
One remarkable aspect of DC biology is their ability to migrate robustly through a
wide range of body tissues (5). We and others have previously explored the influence of
chemokine signals on DC migration and force generation during chemokinesis and
chemotaxis (6–8). One of the most important chemokine receptors on DCs is CCR7,
which interacts with two separate chemokines - CCL19 and CCL21 (9). The interplay
between these chemokine cues is partially responsible for orchestrating the intricate
trafficking patterns of DCs in the body (7,10). However, chemical cues are not the only
signals that DCs receive. Like all cells, migrating DCs must adjust to the mechanical and
geometric characteristics of the microenvironment (11). Geometry, whether physical
topography or the spatial patterning of extracellular matrix ligands, has been shown to
control cell adhesion, guide cytoskeletal organization, determine cell morphology and
regulate migration (12–14). Likewise, stiffness strongly influences the physiology of
many cell types, including their differentiation, adhesion, force generation and migration
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(15–18). In particular, most immune cells respond to differences in the mechanics of
their substrate. Both B cell and T cell activation are regulated by substrate stiffness
(19,20). Neutrophil adhesion, directed migration and force generation increase with
substrate stiffness, and the magnitude of forces generated by macrophages is dependent
on substrate stiffness (21,22). To my knowledge, it is unknown how DCs respond to the
biomechanical and topological properties of their surroundings.
Micropost array detectors (mPADs) were developed as tools for probing cellular
traction forces (23). The geometry of the mPADs can be finely tuned to yield posts with
different shapes, diameters, post-to-post spacing and heights (16,24). The ability to alter
the post height independently of the other parameters is particularly useful, as it allows
for the generation of a family of substrates with similar topography but differing stiffness
(24). In addition, mPADs are more sensitive than other force measurement methods, and
thus are better suited for the measurement of weak forces produced by fast moving cells
such as DCs. I have used mPADs to measure the forces that DCs exert during
chemotaxis and chemokinesis (Chapter 3 and (8,25)). While mPADs are useful tools for
measuring forces of migration, I have not considered how switching the substrate from a
PDMS-coated coverslip to an mPAD array might affect the ability of the DCs to migrate.
It stands to reason that the geometry of the contact points, as presented by the tips of the
posts, might influence the ability of the DC to organize its migration machinery. Also,
the compliance of those contacts might affect the ability of DCs to push off the substrate.
In the work that follows, I use the terms stiffness, elasticity and compliance to
describe how stiff the external environment appears to migrating DCs. Geometry refers
to both the physical structure of the substrate as well as the patterning of ligand. I will

84

specify ligand geometry when I am specifically focusing on that parameter. The word
discretization is used to describe a surface with discontinuous geometry. Finally, I use
the word topology to describe all of these physical characteristics collectively.
The goal of the present study was to determine how DCs respond to the physical
characteristics of their surroundings. I observed that DC migration was unaffected by
variations in stiffness over the range of 1 to 1,000 kPa, but was sensitive to the geometry
of the substrate. I further confirmed the effect of geometry on the dynamics of motility
by testing patterns of ligands printed on PDMS surfaces, and confirmed that the changes
in motility are due to changes in the geometry of ligand presentation. Further, I saw that
DC responses to geometry are regulated by actomyosin contractility and integrin-based
adhesions. Taken together, this work supports the observation that DCs are able to adapt
to and migrate in microenvironments of different geometry, which has implications for
how DCs maneuver in vivo. A greater understanding of how DCs modulate their
migration in different environments can be applied to the development and administration
of immunotherapies to optimize treatment efficacy and delivery.
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MATERIALS AND METHODS
Reagents
Recombinant murine CCL19 was purchased from R&D Systems (Minneapolis,
MN). Lipopolysaccharide (LPS; L4516), DMSO, Pluronics F127, silane
(Trichloro(1H,1H,2H,2H-perfluorooctyl)silane) and bovine fibronectin were obtained
from Sigma-Aldrich (St. Louis, MO). PBS was obtained from Thermo Fisher Scientific
(Hampton, NH). Poly(dimethylsiloxane) (Sylgard 184 Silicone Elastomer) was
purchased from Dow Corning, Midland, MI. Fetal bovine serum was obtained from
Atlanta Biologicals (Flowery Branch, GA). Recombinant GM-CSF was produced from
the B78Hi/GMCSF.1 cell line provided by T. Laufer (University of Pennsylvania,
Philadelphia, PA).

Mice
C57BL/6J mice from Jackson Laboratories and GFP-Lifeact mice bred on the
C57BL/6J background (26) were housed under pathogen-free conditions in the Children’s
Hospital of Philadelphia animal facility. All studies involving animals were reviewed
and approved by the Children’s Hospital of Philadelphia Institutional Animal Care and
Use Committee.

Culture of Bone Marrow Derived DCs (BMDCs)
Primary BMDCs (bone marrow-derived dendritic cells) were prepared following
the protocol of Sixt and Lӓmmermann (27). Mice were euthanized with CO2 gas and
cervical dislocation. Leg bones were harvested and bone marrow was flushed with sterile
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PBS. Cells were spun at 1500 rpm for 10 minutes at 4°C and resuspended at 2.5 x 106
cell/mL. 1 mL of cells, 9 mL R10 media (RPMI 1640 (1x with L-Glutamine and 25 mM
HEPES) + 50 mL heat inactivated FBS + 5 mL pencillin-steptomycin (Thermo Fisher
Scientific, final concentration 100 U/mL pen. and 100 μg/mL strep.)) and 100 μL GMCSF were added to 10 cm Petri dishes. On day three of culture an additional 10 mL R10
and 100 μL GM-CSF were added to each Petri dish. On day six of culture, 10 mL spent
media was gently removed from each dish and replaced with 10 mL fresh R10 and 100
μL GM-CSF. Between days seven and nine DCs were transferred to 6 cm tissue culture
dishes and matured for 24 hours in the presence of 200 ng/mL LPS. Mature DCs were
spun at 1500 rpm for 10 minutes at 4°C and resuspended at 100,000 cells/mL for use in
experiments. DCs were maintained at 37°C under 5% CO2 throughout the culture period
and experiments.

PDMS-coated coverslip Preparation
The following methods were adapted from my previous work (Bendell AC et al,
Submitted). Traditional 2D migration experiments were conducted on PDMS-coated
coverslips printed with fibronectin. Clean 25 mm round glass coverslips (Thermo Fisher
Scientific) were spun with a thin layer of 10:1 PDMS (weight, base:cure) on a Laurell
spinner (4000 rpm, 1 minute) and were cured overnight at 65°C. Coverslips were
mounted onto the bottom of laser-cut one-well dishes with 10:1 PDMS and cured for at
least 3 hours. 60 g of 10:1 PDMS was cast against a flat Silicon wafer in an aluminum
weighing dish and cured overnight at 65°C. The weighing dish was cut away and the
PDMS was carefully peeled away from the silicon wafer. 1 cm2 stamps were cut from
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the flat PDMS. Stamps were sonicated in 200 proof ethanol for 10 minutes, rinsed twice
in DiH2O, dried with N2 gas, inked with 10 μg/mL fibronectin and stored at room
temperature for 2 hours. The PDMS-coated coverslips were treated with UV/ozone for 7
minutes (UVO Cleaner Model 342, Jelight, Irvine, CA) while the fibronectin-coated
stamps were gently rinsed twice in DiH2O and dried with N2 gas. Fibronectin was
transferred from the stamps to the PDMS-coated coverslips through microcontact printing
(28) and the PDMS-coated coverslips were blocked with 0.2 w/v% Pluronic F127 for at
least one hour. The PDMS-coated coverslips were rinsed 2x with PBS and incubated
with PBS at 4°C for at least one hour. Mature DCs were added to the PDMS-coated
coverslips at a concentration of 100,000 cells/mL. Any inhibitors were added at this
point (for concentrations and incubation times, see below). The cells were incubated at
37°C and 5% CO2 throughout the entirety of the experiment. 10 nM CCL19 was used to
stimulate the cells immediately prior to imaging.

mPAD Preparation
Micropost array detectors (mPADs) were prepared following the protocol of Yang
et al. (24). Micropost arrays were prepared from a silicon master by replica molding.
Negative molds were created by casting degassed PDMS (10:1 base to cure) against a
silanized silicon master mold and curing for 12 minutes at 110°C. The negative molds
were gently peeled away from the silicon master, plasma treated (SPI Supplies Plasma
Prep II, West Chester, PA) for 7 seconds, and silanized overnight. PDMS (10:1 base to
cure) was added to the negative molds and degassed for 30 minutes to remove any air
bubbles. 25 mm round glass coverslips were cleaned with N2 gas and plasma treated for
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90 seconds. The molds were placed, fresh PDMS side down, onto the cleaned coverslip
and cured at 110°C for 20 hours. The mPADs were gently peeled away from the
negative molds, immediately submerged in 200 proof ethanol and supercritical dried
(SAMDRI-PVT-3D, Tousimis Corporation, Rockville, MD) in liquid CO2. Circular
holes were laser cut from the bottom of one well dishes. mPAD coverslips were secured
to the bottom of the one well dishes with 10:1 PDMS and the seal was cured overnight at
65°C.
10 μg/mL fibronectin was microcontact printed onto the post tips, following the
same procedure as above with minor modifications. After stamping the mPADs, 1 mL of
200 proof ethanol was added and the stamp was gently flicked off the micropost array.
The ethanol was immediately diluted to 60% with diH2O. The mPADs were gently
rinsed three times with diH2O. The post tips were blocked with 0.2 % Pluronic F127 for
1 hour at room temperature, rinsed three times with sterile diH2O and stored at 4°C
overnight. The following day, 1 mL of mature DCs (100,000 cells/mL) was added to the
mPAD. If inhibitors were being used they were added at this point and cells were
incubated at 37°C for the desired amount of time (see below). Motility was stimulated
with 10 nM CCL19 immediately before moving the dish to the microscope stage, and
cells were allowed to settle on the micropost array before imaging began.

Ligand Patterning on PDMS-Coated Coverslips
Patterned stamps were created by casting polymer against a patterned silicon
wafer. First, a rigid polymer solution was created by combining 3.4 grams of (7.0-8.0%
Vinylmethylsiloxane)-Dimethylsiloxane Copolymer, Trimethylsiloxy Terminated
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(Gelest, Inc.); 1.0 grams of (25-35% Methylhydrosiloxane)-(Dimethylsiloxane)
Copolymer (Gelest, Inc.); 4 drops of modulator 2,4,6,8-Tetramethyl-2,4,6,8tetravinylcyclotetrasiloxane (Sigma Aldrich); and 4 drops of catalyst Platinum(0)2,4,6,8-tetramethyl-2,4,6,8-tetravinylcyclotetrasiloxane complex solution (Sigma
Aldrich). The solution was mixed thoroughly and cast against a patterned silicon wafer.
Large, surface-trapped air bubbles were removed by gently blowing N2 gas over the layer
of polymer and the polymer was baked for 40 minutes at 50°C. A soft PDMS layer (22
grams of 10:1 PDMS (weight, base:cure)) was poured over the rigid polymer and the
stamp was baked overnight. The next day, the polymer was gently peeled away from the
wafer and the stamps were trimmed. Microcontact printing was performed as described
above. The only difference was the use of fluorescently labeled fibronectin (488conjugated) to visualize stamped patterns.

Inhibitors and Antibodies
Inhibitors and antibodies were added to one-well dishes along with mature DCs
(at 100,000 cells/mL) prior to imaging. Cells were maintained at 37°C unless otherwise
noted. The following concentrations and incubation times were used: blebbistatin
(B0560; Sigma-Aldrich, St. Louis, MO) at 2 μM for 1 hour; Y-27632 (68800;
Calbiochem, San Diego, CA) at 10 μM for 30 minutes; Exoenzyme C3 Transferase
(CT04; Cytoskeleton Inc., San Diego, CA) at 1 μg/mL for 4 hours; LY294002 (99015;
Cell Signaling Technology, Danvers, MA) at 50 μM for 1 hour; CK666 (SML006;
Sigma-Aldrich, St. Louis, MO) at 10 μM for 1 hour; α5 and β1 antibodies (14-0493-85
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and 14-0292-85, respectively; eBioscience, San Diego, CA) at 5 μg/mL for 10 minutes at
room temperature then 10 minutes at 37°C.

Live Cell Imaging
Mature DCs were imaged at 10x by phase microscopy on a Nikon Eclipse TE300
(Nikon, Melville, NY) with MetaMorph software (MetaMorph Inc., Nashville, TN).
Images were collected at multiple positions for one hour at one minute intervals using a
motorized stage. Cells were maintained at 37°C and 5% CO2 throughout imaging.

Image Analysis and Quantification
Cell migration was analyzed with the Manual Tracking plugin in ImageJ
(http://rsbweb.nih.gov/ij). Cells were tracked over time by manually specifying their
centroid positions in each frame. Cells that were apoptotic or completely stationary were
excluded, as well as any cells in contact with other cells. The list of x- and y-coordinates
obtained from ImageJ was further analyzed with a custom-written MATLAB
(Mathworks, Natick, MA) script. The MATLAB script computed the MSD of the
compiled list of cell tracks and used the Dunn equation 〈
1−

−

〉=2

−

to fit speed (S) and persistence (P) (29). The random motility

coefficient was calculated from the speed and persistence as follows:

=

, where n

specifies the dimensionality (30).
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Statistical Analysis
I used a one-way ANOVA along with a Tukey’s Post Hoc Test to determine
statistical significance. Statistically significant differences at p < 0.05 were marked with
an asterisk (*) and differences at p < 0.01 were marked with a double asterisk (**).

Atomic Force Microscopy
All experiments were carried out at room temperature using a Bruker Bioscope
Catalyst AFM (Billerica, MA, USA). A spherical tip from Novascan (Boone, IA, USA)
was used with a nominal spring constant of 0.06 N/m and a nominal tip radius of 500 nm.
The cantilever spring constant was calibrated using Nanoscope software (Bruker). The
AFM was operated in the fluid contact mode at a force distance curve acquisition
frequency of 2 Hz.
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RESULTS
Dendritic Cell Migration is Affected by the Underlying Substrate
I have previously quantified DC chemokinesis on continuous PDMS surfaces,
made by uniformly spin coating PDMS on a glass coverslip, and I have measured force
generation by DCs on discrete PDMS microposts (Chapter 3 and (8,25)). Although I
have always considered these experiments to be complementary, important differences
between the two experimental systems leave open key questions about whether migration
is affected by the stiffness and/or the geometry of the underlying substrate. To address
these questions, I measured the random migration of DCs on mPADs, and compared the
data to my previous results for DCs randomly migrating on PDMS-coated coverslips. In
both cases, the surfaces were printed with fibronectin to ensure cell adhesion, and
blocked with Pluronic F127 to restrict cell attachment to the printed region. 10 nM
CCL19 was also added to DCs to stimulate motility. DCs were able to move and had
similar morphologies on the two surfaces (Figure 4.1A and B).
Sample trajectories from DCs on PDMS-coated coverslips and mPADs are shown
in Figure 4.1C and D, respectively. As a first step of analysis, I used the trajectories to
calculate the mean squared displacement (MSD) as a function of time. When plotted on a
log-log scale, the slope of this curve provides a quantitative description of the form of
migration. For DCs migrating randomly on either PDMS-coated coverslips or
microposts, I found the MSD versus time had a slope of 1 on each surface, indicating
purely random migration (Figure 4.1E). I next analyzed this data using the Dunn
equation (Equation 4.1) to determine the speed (S) and persistence time (P) (29). I used
speed and persistence time to calculate two additional
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Figure 4.1. DCs on PDMS-coated coverslips persist in the same direction for longer
periods of time.
A,B) Sample phase contrast images of DCs on mPADs (A) and PDMS-coated coverslips
(B). DCs were plated on 10 μg/mL fibronectin and stimulated with 10 nM CCL19.
Colored lines show sample cell trajectories at each time point. Trajectories are longer
and more linear for DCs on PDMS-coated coverslips than for DCs on mPADs. C,D)
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Sample cell tracks for DCs on mPADs (C) and PDMS-coated coverslips (D). In these
specific samples, DCs on PDMS-coated coverslips cover a larger area during random
migration. Over the entire population of cells tested for each condition, there was no
statistically significant difference in this parameter (see random motility coefficient,
Figure 4.5D). E) The Mean Squared Displacement of both cell populations shows a
linear fit with time, on a log-log scale, with slope approximately equal to 1 (gray dashed
line), indicating diffusive migration
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quantitative features of motility—the persistence length and random motility
coefficient—given by Equations 4.2 and 4.3, respectively.

〈

〉=2

−

1−

−

Equation 4.1
=
Equation 4.2
=
Equation 4.3

The values of these metrics on the two types of materials are shown in Figure 4.2.
I previously performed a thorough analysis of WT DCs on PDMS-coated coverslips, and
report these values here as reference (8). While the DCs migrated diffusively on mPADs,
just as they did on PDMS-coated coverslips, the method by which DCs achieved their
random migration was quite different. DCs on PDMS-coated coverslips migrated at a
speed of 4.00 ± 0. 18 μm/min and persisted for 4.88 ± 0.46 min before changing
directions (Figure 4.2A, B). DCs on mPADs exhibited a modest, but significant increase
in speed (4.92 μm/min), and persisted for a significantly shorter time (2.35 min) before
changing direction. The significant reduction in persistence time also led to a reduction
in persistence length (Figure 4.2C). The decrease in persistence time also contributes to a
reduction in the area covered during migration (reflected in a reduced value of the
random motility coefficient), although this reduction does not reach significance (Figure
4.2D). By examining the cell trajectories on the PDMS-coated coverslip and mPAD
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surfaces, I can see that the majority of DCs on the PDMS-coated coverslips migrate over
large distances. In contrast, there appear to be two separate populations of DCs on
mPADs, with some DCs exhibiting long trajectories and some DCs exhibiting more
circuitous trajectories huddled around the origin. This large variance in the phenotype of
DC migration on
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Figure 4.2. DCs migrated differently on PDMS-coated coverslips and mPADs.
A) The average speed of DCs on mPADs is significantly greater than that of DCs on
PDMS-coated coverslips. B) The persistence time of DCs on mPADs is drastically
reduced, as compared to the persistence time of DCs on PDMS-coated coverslips. C)
The reduction is persistence time is carried through to a reduction in the persistence
length. D) The combination of the increase in average speed and decrease in persistence
time, results in a non-significant difference in the overall diffusivity. Figures represent
average values ± SEM, for > 650 DCs from at least three independent experiments per
98

condition. PDMS-coated coverslip values correspond to my previous data on
characterizing DC migration on PDMS surfaces (Figure 3.2). Statistical significance
calculated with single factor ANOVA and post hoc Tukey test. Indicates significant
difference compared to PDMS-coated coverslip. *p<0.05, **p<0.01
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mPADs accounts for the failure of the decrease in random motility coefficient to reach
significance. Taken together, these measurements indicate that DCs are able to undergo
random migration on mPADs, but the characteristics of their migration are influenced by
the geometry of the substrate.

Dendritic Cells Respond to Geometry and Not Stiffness
After determining that DC migration is affected by the topology of the substrate, I
sought to determine whether the DCs were responding to its geometry or its elasticity.
The coverslips are coated with PDMS, the same material used to generate the mPAD
surfaces. However, while the coverslip is covered with a continuous layer of PDMS, the
mPAD is molded into a discrete array of posts with adjustable geometry (diameter and
spacing of posts) and adjustable elasticity (set by the height of the posts) (24). Both
substrates present a 2D, fibronectin-printed surface to migrating DCs. However, the
stiffness of the PDMS-coated coverslip is two orders of magnitude greater than that of the
tall mPAD I generally use, and the ligand-coated surface is discontinuous rather than
uniform.
Both the geometry and stiffness of the microenvironment have been known to
influence the migration of many different types of cells, making either factor a possible
explanation for the changes in DC migration I observe on mPADs (11). Since most
immune cells show functional dependence of motility on substrate stiffness, I
hypothesized that DCs would also be responsive to this feature of the material (21,22,31).
To test whether the elasticity of the mPADs affects the migration of DCs, I repeated the
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migration experiments using two additional mPADs, called “short” and “medium.”
(Table 4.1). Each mPAD array has the same
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Table 4.1. Dimensions and stiffness of different mPADs.
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2-dimensional cross sectional geometry, with the same post diameter (1.83 μm) and post
spacing (~ 3 μm), but they have different heights which ultimately leads to different
stiffnesses (24). The stiffness of "tall" mPADs was approximately 1 kPa, "medium"
mPADs were 10 kPa, and "short" mPADs were 103 kPa. In experiments on coverslips, I
spun the surface with a layer of 10:1 PDMS (base to cure by weight), which leads to a
stiffness on the order of 100 kPa (Figure 4.3). By quantifying DC migration across this
range of mPAD stiffnesses, I can effectively tease out the effect of stiffness while
keeping substrate geometry constant. If DC migration depends on stiffness, I would
expect migration to be different on the different surfaces. As shown in Figure 4.4A, the
average speed of DC migration is similar on all three mPAD surfaces. Moreover, there is
no difference in the persistence time on the different mPAD surfaces (Figure 4.4B).
Consistent with my earlier finding, however, DCs exhibit diminished persistence tiem on
all mPADs as compared with PDMS-coated coverslips. These results indicate that DC
migratory behavior is unaltered by changes in stiffness over a two-log range.
Next, I wanted to determine if this geometry dependence was due to physical
topography of the substrate (i.e. discrete micropillars vs. continuous surface) or the
geometry of ligand printed on the surfaces. I addressed this question by spatially
patterning ligand on PDMS-coated coverslips (Figure 4.5A). This provided a migration
surface in which I can probe ligand geometry independently of the physical structure of
the substrate. DC migration on these patterned PDMS-coated coverslips was quantified
as described above, and average speed and persistence time were compared to the values
for migration on the continuously-printed PDMS-coated coverslips and mPADs (Figure
4.5B, C). DCs migrating on these patterned surfaces migrated significantly faster than
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DCs on continuously printed PDMS-coated coverslips, while their speed was
indistinguishable from that of DCs on mPADs (Figure 4.5B).
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Figure 4.3. Approximate stiffness of PDMS-coated coverslips.
Multiple points on two separate spin-coated coverslips were probed with a soft AFM tip.
The measurements were fit to two different models. The contact point model is optimal
for soft materials measured with a soft tip. The linearized model is optimal for hard
materials measured with a hard tip. Due to system limitations (i.e. soft tip), the values
reported are only estimates of surface stiffness. Neither model is ideal, but I am
confident in reporting an order of magnitude stiffness of 100’s of kPa. Figure provided
by Daniel Blumenthal.
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Figure 4.4. DCs respond to mPAD geometry, not stiffness.
A) There is no trend in the average speed of DCs on the different mPADs. B) The
persistence time of DCs is significantly reduced on all mPADs, regardless of stiffness.
Figures represent average values ± SEM, for > 180 DCs from at least three independent
experiments per condition. PDMS-coated coverslip values correspond to my previous
data on characterizing DC migration on PDMS surfaces (8). Statistical significance
calculated with single factor ANOVA and post hoc Tukey test. Asterisks indicate
significant difference compared to PDMS-coated coverslip. *p<0.05, **p<0.01. There is
no statistically significant difference between the tall mPAD and the short and medium
mPADs.
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Figure 4.5. DCs respond to geometry of printed ligand.
A) Patterned stamps were used to transfer 488-conjugated fibronectin to PDMS-coated
coverslips. Tracking was performed on the pattern located in the top right corner, which
closes matches the mPAD geometry. This large dot pattern has the following
dimensions: diameter of circular islands is 2 µm and centroid-to-centroid spacing is 5
µm. B) The average speed of DCs on PDMS-coated coverslips printed with islands of
fibronectin is significantly greater than that on PDMS-coated coverslips printed with
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continuous fibronectin, but indistinguishable from that on mPADs. C) The persistence
time of DCs on both mPADs and PDMS-coated coverslips printed with islands of
fibronectin is significantly lower than that on PDMS-coated coverslips printed with
continuous fibronectin. Figures represent average values ± SEM, for > 650 DCs from at
least three independent experiments per condition. PDMS-coated coverslip values
correspond to my previous data on characterizing DC migration on PDMS surfaces
(Figure 3.2). Statistical significance calculated with single factor ANOVA and post hoc
Tukey test. Asterisk indicates significant difference compared to PDMS-coated
coverslip. *p<0.05, **p<0.01. There are no statistically significant differences between
the tall mPAD and the patterned PDMS-coated coverslips.
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DCs on patterned PDMS-coated coverslips also displayed a significant difference in
persistence time, matching my observations for persistence time on mPADs. These
results indicate that DC migration responds to the discretization of printed ligand
geometry and is not affected by the physical topography of the environment.
Finally, I wanted to know how sensitive DCs are to differences in geometry. If
the mPADs used thus far allowed us to modulate how often DCs turn, I hypothesized that
altering the mPAD geometry could further manipulate DC turning behavior. To test this
relationship, I prepared mPADs with smaller diameter posts and interpost spacing and
tracked DC migration. While the mPADs I used previously have a diameter of 1.8 μm
and post-to-post spacing of ~3 μm, the new smaller mPADs have a diameter of 800 nm
and post-to-post spacing of ~2 μm (Table I). With smaller feature sizes, DCs with the
same area will interact with more posts on the small mPADs than they do on the larger
diameter, tall mPADs. Quantification of persistence time revealed no differences in
turning behavior between DCs migrating on larger and smaller diameter posts (Figure
4.6). Therefore, I conclude that migratory DCs are able to respond to large-scale
differences in geometry (i.e. continuous vs. discrete ligand presentation) but are unable to
discern differences in geometry on the scale of 1 μm.

Dendritic cells sense differences in geometry through myosin contractility, intregin-based
adhesions and reorganization of the actin cytoskeleton
To gain an understanding of how the substrate geometry affects subcellular
organization and signaling during DC migration, I used GFP-Lifeact DCs to visualize Factin organization. On PDMS-coated coverslips, F-actin was highly concentrated at the
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periphery of the cell, forming lamellipodia and filopodia (Figure 4.7A). When DCs were
plated on mPADs, the actin
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Figure 4.6. DCs do not detect micron-scale differences in geometry.
A) The average speed of DCs on smaller diameter mPADs is significantly greater than
that on PDMS-coated coverslips, but indistinguishable from that on larger diameter
mPADs. B) The persistence time of DCs on smaller diameter mPADs is significantly
lower than that on PDMS-coated coverslips, but is again indistinguishable from that on
larger diameter mPADs. Figures represent average values ± SEM, for > 290 DCs from at
least three independent experiments per condition. PDMS-coated coverslip values
correspond to my previous data on characterizing DC migration on PDMS surfaces (8).
Statistical significance calculated with single factor ANOVA and post hoc Tukey test.
Asterisks indicate significant difference compared to PDMS-coated coverslip. *p<0.05,
**p<0.01. There are no statistically significant differences between the tall mPAD and
the small mPAD.
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Figure 4.7. The actin cytoskeleton is reorganized on mPADs.
Representative GFP-LifeAct DCs plated on PDMS-coated coverslips (A) or mPADs (B
and C). Cells were plated on 10 μg/mL fibronectin and stimulated with 10 nM CCL19.
Scale bars represent 10 μm. A) On PDMS-coated coverslips, actin is concentrated at the
periphery. B) On mPADs, actin is redistributed into rings at the periphery of engaged
microposts.
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showed a very different distribution, with high levels of GFP signal surrounding each
engaged post under the cell body (Figure 4.7B). The process of ring formation is very
dynamic, with the actin intensity in individual rings fluctuating on a time-scale of 1
minute, which is shorter than the persistence time (2.35 ± 0.25 min). The presence of
these actin rings provides additional evidence that DCs detect differences in PDMScoated coverslips and mPADs.
I next aimed to clarify the mechanisms involved in the ability of DCs to respond
to discretizations in geometry through the use of small molecule inhibitors. Since I
observed differences in the actin organization of DCs on PDMS-coated coverslips and
mPADs, I first used CK666 to investigate actin polymerization mediated by the Arp2/3
complex (orange bars in Figure 4.8). In the next chapter, I will show that inhibition of
the Arp2/3 complex led to significant reductions in average speed and had no effect on
persistence time on PDMS-coated coverslips (8). Treatment with CK666 had no effect
on DC morphology on either PDMS-coated coverslips or mPADs (Figure 4.8C).
Addition of CK666 to DCs on mPADs led to a significant decrease in speed and had no
influence on persistence time (Figure 4.8A, B). Although speed is reduced in DCs on
both PDMS-coated coverslips and mPADs when CK666 is present, the significant
difference is speed between DCs on mPADs and PDMS-coated coverslips remains.
(Figure 4.8A, B). Thus, I conclude that while Arp2/3 complex activity is important for
migratory speed during DC chemokinesis, it does not contribute to geometry sensing.
The next pathway I probed was myosin contractility, by direct inhibition of
myosin with blebbistatin (blue bars in Figure 4.8). At a concentration of 2 μM, cells
remained viable but displayed elongated morphology (Figure 4.8C). I saw no significant
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changes in average speed or persistence time under the influence of blebbistatin on
mPADs (Figure 4.8A, B). I did
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Figure 4.8. DC response to substrate geometry is influenced by myosin contractility.
A) The average speed of DCs on both PDMS-coated coverslips and mPADs is unaffected
by myosin inhibition and is significantly reduced by inhibition of the Arp2/3 Complex.
B) The persistence time of DCs on PDMS-coated coverslips is significantly reduced in
the presence of the myosin inhibitor blebbistatin. Blebbistatin has no effect on DC
persistence on mPADs. Arp2/3 Complex inhibition has no effect on persistence time for
DCs on either PDMS-coated coverslips or mPADs. C) Sample phase contrast images of
DCs inhibited with CK666 (left) or blebbistatin (right), on PDMS-coated coverslips (top)
and mPADs (bottom). Colored lines indicate sample cell trajectories. Under these two
inhibitor conditions DCs turn at similar frequencies. DCs were plated on 10 μg/mL
fibronectin and stimulated with 10 nM CCL19. Figures represent average values ± SEM,
for > 290 DCs from at least three independent experiments per condition. PDMS-coated
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coverslip values correspond to my previous data on characterizing DC migration on
PDMS surfaces (8). Statistical significance calculated with single factor ANOVA and
post hoc Tukey test. Asterisks indicate significant difference compared to PDMS-coated
coverslip without inhibitors. *p<0.05, **p<0.01. Crosses indicate significant difference
compared to tall mPAD without inhibitors. †p<0.05, ††p<0.01.
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however, see a significant decrease in persistence time of DCs on PDMS-coated
coverslips in the presence of blebbistatin (Figure 4.8B). Indeed, the persistence time of
blebbistatin-treated DCs on PDMS-coated coverslips was indistinguishable from that of
untreated DCs on mPADs. This indicates that myosin contractility contributes to
geometry sensing, since inhibition of this pathway eliminates the ability of DCs to sense
differences in geometry between the two surfaces.
Finally, I used antibodies to impair integrin-mediated adhesions. Both of my
surfaces were printed with fibronectin, so I chose to specifically block the two subunits of
the major fibronectin integrin in DCs: α5 and β1. I chose antibody concentrations that
would only partially block integrin function (5 μg/mL final concentration for each
inhibitor, approximately 10% of the concentration I would have used for complete
blocking), thus allowing for continued adhesion but reduced availability of active
integrins. DCs were able to adhere and migrate on the PDMS-coated coverslip and
mPAD surfaces under these conditions (Figure 4.9A). Blocking of either subunit had no
effect on the average speed or persistence time of DCs on PDMS-coated coverslips
(Figure 4.9A, B). In contrast, blocking either integrin subunit led to a significant
decrease in average speed and significant increase in persistence time on mPADs.
Indeed, treatment with either antibody effectively eliminated the geometry-induced
differences in DC migration; the average speed and persistence time became
indistinguishable for DCs on mPADs and PDMS-coated coverslips. Therefore, I
conclude that integrin adhesion to fibronectin plays a major role in the ability of DCs to
respond to discrete substrate geometry. Taken together, these results show that the
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response of DCs to substrate geometry is a dynamic process mediated through myosin
contractility, integrin-based adhesions and cytoskeletal reorganization.
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Figure 4.9. DC response to substrate geometry is influenced by integrin-based adhesions.
A) Blocking of either integrin subunit (α5 or β1) had no effect on the average speed of
DCs on PDMS-coated coverslips, but significantly reduced the speed of DCs on mPADs.
B) Likewise, blocking of either integrin subunit had no effect on persistence time of DCs
on PDMS-coated coverslips, but significantly increased the persistence time of DCs on
mPADs. C) Sample phase contrast images of DCs blocked with antibodies against α5
(left) or β1 (right), on PDMS-coated coverslips (top) and mPADs (bottom). Under these
two inhibitor conditions, cells persist for long periods of time on mPADs and often
exhibit an elongated morphology pointed in the direction of migration. Scale bars equal
20 μm. DCs were plated on 10 μg/mL fibronectin and stimulated with 10 nM CCL19.
Figures represent average values ± SEM, for > 290 DCs from at least three independent
experiments per condition. PDMS-coated coverslip values correspond to my previous
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data on characterizing DC migration on PDMS surfaces (8). Statistical significance
calculated with single factor ANOVA and post hoc Tukey test. Indicates significant
difference compared to PDMS-coated coverslip without inhibitors. *p<0.05, **p<0.01.
Crosses indicate significant difference compared to tall mPAD without inhibitors.
†p<0.05, ††p<0.01.
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DISCUSSION
We have previously characterized the traction forces of motile DCs using mPADs
(25). During chemotaxis, DCs produce a total force with magnitude of 18 ± 14 nN/cell
(25). The average force per post is on the order of half a nanoNewton, with larger forces
located at the leading edge (25). Traction forces are significantly reduced when either
actin polymerization or myosin motor activity are inhibited (25). In the next chapter, I
will discuss the quantification of DC forces during chemokinesis and identify actinbinding proteins critical for force generation. In the present study, I used mPADs to
study the dynamics of cell migration. I observed that DCs are responsive to the
differences in the substrates on which they are migrating. These differences in migration
are due to the geometry and of the substrate and not stiffness. Furthermore, I showed that
DCs are able to sense these topographical differences through actomyosin contractility
and integrin engagement.
I have previously characterized DC random migration on 2D fibronectin-coated
glass and PDMS surfaces. In these settings, DCs appear to be insensitive to the level of
fibronectin, the level of chemokine present and the type of underlying substrate,
migrating at a consistent speed of ~4 μm/min (Ricart BG, Bendell AC unpublished
results). DCs have also been shown to migrate well in 3D gels and under confinement
and are capable of migrating without the use of integrins (32,33). After quantifying
differences in the random migration of DCs on posts, I sought to identify whether
stiffness or geometry was the causative factor. I developed a method for exploring the
response of DCs to substrate stiffness while keeping the substrate geometry constant. I
achieved this through the use of a set of mPADs with different post heights. Each mPAD
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had the same 2D geometry, but the stiffness of the posts was inversely correlated with
post height. In terms of physiological relevance, the softest mPAD (~1 kPa) is similar to
the stiffness of endothelial tissue, the medium mPAD (~10 kPa) is similar to the stiffness
of skeletal muscle and the stiffest mPAD (~1,000 kPa) starts to approach the compliance
of rigid materials such as bone (34). Somewhat surprisingly, I discovered that DCs are
insensitive to stiffness but react to differences in substrate geometry. Since DCs are
present throughout the body and in a variety of different tissues, each having a
characteristic stiffness, it would be useful for DCs to be able to migrate well in a variety
of different environmental compliances.
After determining that DCs respond to geometry, I performed experiments to
determine whether this sensitivity is due to the physical geometry or ligand patterning.
Printed ligand geometry significantly affects the migration of other immune cells such as
neutrophils (14), and I thought it likely to affect DC migration. When studying migration
on different surfaces, multiple variables are affected, and it has often been difficult to
probe the effect of the individual parameters on cell migration. For example, Frey et al.
showed that 3T3 fibroblasts migrating on microposts moved faster and turned more
frequently than fibroblasts on continuous surfaces (35). Even though fibronectin was
adsorbed to the entire substrate, the cells preferentially migrated on the post tips and not
the interpost regions (35). As a result, cells were exposed to discrete ligand and discrete
substrate, and it was not determined whether the influence on migration was due to
physical topography or the discrete pattern of ligand the cells encountered. In a separate
study, Wójciak-Stothard et al. exposed macrophages to grooved substrates containing
regularly spaced, parallel lines (12). In this environment, macrophages were shown to
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migrate in straight lines, following the direction of the ridges and grooves, thus leading to
a significantly increased persistence time (12). Again, it is not clear what aspect of the
environment influences cell migration, as ligand patterning was restricted by the substrate
structure. My approach at printing patterns on a flat substrate permitted us to separate the
effect of physical geometry from ligand geometry, and allowed us to determine that DCs
respond directly to ligand patterning and not substrate structure. It is unknown how
sensitive DCs are to ligand patterning, but it is clear that they can robustly differentiate
continuous from discrete ligand presentation.
I next asked what molecules and pathways are involved in the ability of DCs to
sense geometry. Since I previously showed that myosin is necessary for interactions with
post arrays and transmission of traction forces (25), it seemed likely that myosin would
also be important for geometry sensing and migration. My experiments reveal that
myosin inhibition reduces persistence time of DCs on flat surfaces, to levels similar to
that seen for DCs on posts. However, myosin inhibition of DCs on posts is unable to
further decrease persistence time. This suggests that myosin contractility is indeed
important for DC migration, in particular for regulation of persistence time. The
normalization of migration on flat surfaces and posts in the presence of blebbistatin has
also been shown for fibroblasts (although the authors focused on normalization in terms
of speed and not persistence time) (35).
My experiments with GFP-Lifeact DCs revealed that the organization of the actin
cytoskeleton is affected by substrate geometry. Geometry-dependent reorganization of
actin has also been observed in macrophages migrating along a series of ridges and
grooves (12). In these cells, actin was highly concentrated at the boundary of the ridge
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and groove interface, just as I see actin at the boundary of the post and interpost regions
(12). Others have shown that the actin cytoskeleton is reorganized in cells adhered to
discrete patterns of ligand (36), but unlike my observations, the actin is concentrated into
solid circles over the patches and not into rings. These rings are dissimilar to other actin
structures typically observed in DCs, such as podosomes, which have the appearance of
punctate actin spots surrounded by a ring of adhesion protein (37). My observations
suggest that actin is actively involved in the response of DCs to environmental geometry.
The specific actin pathway responsible for this process has not been identified, but
inhibition studies with CK666 have ruled out the Arp2/3 Complex.
A final pathway I chose to investigate was the role of integrin adhesion. Since my
surfaces are coated with fibronectin, I chose to inhibit the two subunits of the main
fibronectin integrin in DCs, α5β1. While DCs in 3D environments have been shown to be
capable of migrating without the use of integrins, I and others have shown that DCs
migrating in 2D do indeed employ integrins (33). When I partially inhibit either integrin
subunit in DCs migrating on posts I see a complete elimination of geometry dependence.
Thus, integrin engagement is critical for the ability of DCs to sense geometry while
migrating in 2D. Future work should be performed to identify the specific components of
myosin contractility, adhesion formation and the actin cytoskeleton that are involved in
responses to geometry.
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ABSTRACT
Dendritic cell migration to the T-cell-rich areas of the lymph node is essential for
their ability to initiate the adaptive immune response. While it has been shown that the
actin cytoskeleton is required for normal DC migration, the role of many of the individual
cytoskeletal molecules is poorly understood. In this study, I investigated the contribution
of the Arp2/3 complex binding protein, haematopoietic lineage cell-specific protein 1
(HS1), to DC migration and force generation. I quantified the random migration of HS1 /-

DCs on 2D micro-contact printed surfaces and found that in the absence of HS1, DCs

have greatly reduced motility and speed. This same reduction in motility was
recapitulated when adding Arp2/3 complex inhibitor to WT DCs or using DCs deficient
in WASP, an activator of Arp2/3 complex-dependent actin polymerization. I further
investigated the importance of HS1 by measuring the traction forces of HS1 -/- DCs on
micropost array detectors (mPADs). In HS1 deficient DCs, there was a significant
reduction in force generation (3.96 ± 0.40 nN/cell) compared to WT DCs (13.76 ± 0.84
nN/cell). Interestingly, the forces generated in DCs lacking WASP were only slightly
reduced compared to WT DCs. Taken together, these findings show that HS1 and Arp2/3
complex-mediated actin polymerization are essential for the most efficient DC random
migration and force generation.
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INTRODUCTION
Dendritic cells (DCs) are potent antigen presenting cells (APCs) which possess
the unique ability of linking the innate and adaptive immune responses (2,3). Immature
DCs reside in a variety of tissues and continually sample their environment for antigens.
Once DCs encounter a pathogen, they capture it and load antigenic fragments onto MHC
molecules on their surface for presentation to other immune cells. Pathogen recognition
also triggers DC maturation, which is characterized by a variety of phenotypic and
functional changes (reviewed in (4,5)). Of particular interest to us is a dramatic switch
from a slowly moving, tissue resident cell to a highly migratory cell (6). This increased
level of migration allows DCs to exit peripheral tissues and travel via the lymphatic
system to T cell rich regions of the lymph nodes, where they activate T cells and launch a
specialized immune response (7).
Cell migration depends on coordinated interactions among the different
components of the actin cytoskeleton (8,9). At the front of a migrating cell, rapid actin
polymerization forms protrusive structures that help to push the plasma membrane
forward. One such structure found in DCs is the lamellipodium (Figure 5.1A) (10),
which is formed by branched actin polymerization driven by the actin related protein
(Arp) 2/3 complex (Figure 5.2B) (11,12). While the Arp2/3 complex alone is a weak
actin nucleator, the rate of Arp2/3 mediated actin polymerization is increased in the
presence of a class of proteins known as nucleation promoting factors (NPFs) (13–16).
These proteins bind to both actin and the Arp2/3 complex and enhance Arp2/3 complexdependent nucleation of branched actin filaments. One such NPF is hematopoietic
lineage cell-specific protein 1 (HS1).
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HS1 (also known as HCLS1 and LckBP1) is a 75 kDa protein expressed
exclusively in hematopoietic cells (17,18). HS1 is the only known class II NPF in
hematopoietic cells and is
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Figure 5.1. DCs contain actin rich structures at the leading edge and show defects in
migration when HS1 is eliminated.
(A) Sample images of GFP-Lifeact DCs showing GFP-labeled actin filaments (top) and
phase contrast images of the same cells (bottom). Scale bar equals 20 μm. (B) Sample
images of GFP-Life-act transduced HS1 -/- DCs showing GFP-labeled actin filaments
(top) and bright field images of the same cell (bottom). (C,D) Cell tracks for (C) WT and
(D) HS1 -/- DCs during a representative chemokinesis experiment. ≥ 110 cells were
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tracked per condition for a period of 2-3 hours. (E) Average percentage of motile cells.
Figures represent average values ± SEM, for > 1000 DCs from at least three independent
experiments per condition. Statistical significance calculated with single factor ANOVA
and post hoc Tukey test. Indicates significant difference compared to WT DCs. *p<0.05,
**p<0.01
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Figure 5.2. HS1 stabilizes branched actin filaments at the leading edge of DCs.
(A) Structure of HS1. The NTA domain, shown in red, binds to the Arp 2/3 complex.
The helix-turn-helix domain and coiled-coil domains, shown in blue, bind to F-actin. A
proline rich domain, SH3 domain and important tyrosine residues are located at the Cterminus. (B) Cartoon representation of branched actin structure in lamellipodia. Red
represents the Arp 2/3 Complex and blue represents actin. HS1 (chain of colored circles)
is thought to stabilize actin branch points by simultaneously binding the Arp 2/3
Complex and neighboring F-actin.
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highly homologous with the widely studied protein cortactin (19). It contains an Nterminal acidic (NTA) region, which binds to the Arp2/3 complex, followed by a helixturn-helix region and a coiled-coil domain, both of which bind to F-actin and are required
for proper Arp2/3 complex activation and branched actin polymerization (Figure 5.2A)
(15,20). HS1 has been shown to increase the rate of Arp2/3 complex mediated actin
polymerization, prolong the half-life of existing branched actin filaments and regulate
lamellipodial dynamics (15,20–22). It has also been shown that HS1 interacts with
another NPF—Wiskott Aldrich Syndrome Protein (WASP) (23). Unlike HS1, WASP is
a class I NPF, which uses its VCA domain to bind to monomeric actin and the Arp2/3
complex (24). Through its interactions with the Arp2/3 complex and WASP, HS1 is able
to shape the dynamics of branched actin networks.
HS1 is expressed at high levels in mature dendritic cells (25), yet the exact role it
plays in DC migration is not clear. Initial studies revealed that HS1 could be eliminated
from dendritic cells without altering their morphology or viability (23,25). Nonetheless,
there are a few differences in the structure and function of HS1 -/- DCs. HS1 -/- DCs
adhere and spread normally, but they form disorganized and overly dynamic actin
structures, such as podosomes and lamellipodia, and have defective antigen capture via
receptor-mediated endocytosis (23,25). Previous work by Klos Dehring et al. highlighted
the importance of HS1 in dendritic cell migration, in particular during chemotaxis (23).
The authors found that HS1 -/- DCs are able to migrate across transwells in response to
CCL19 or CCL21 to the same degree as WT DCs, and have unaltered expression of
chemokine receptors. However, when placed in a microfluidic gradient generator, HS1 -/DCs migrated significantly faster than WT DCs and were less able to persistently migrate
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in the direction of the chemokine gradient. These findings reveal that the long-term
ability of HS1-/- DCs to reach a target location is not significantly altered, but that the
manner in which DCs migrate to the target is affected. Building upon this study, I sought
to determine if HS1 impacts other aspects of DC migration. Using motility assays and
micropost array detectors (mPADs), I quantified the random migration and force
generation of HS1 -/- DCs, respectively. In addition, I used both Arp2/3 complex
inhibitor and WASP -/- DCs to elucidate the molecular mechanisms through which HS1
acts. I found that HS1 is required for efficient migration and force generation, and I
hypothesize that HS1 likely influences DC migration through its interaction with the
Arp2/3 complex.
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MATERIALS AND METHODS
Reagents
Recombinant murine CCL19 was purchased from R&D Systems (Minneapolis,
MN). Lipopolysaccharide (LPS; L4516), CK-666 (Lot: 043M4606V) DMSO, Pluronics
F127, silane (Trichloro(1H,1H,2H,2H-perfluorooctyl)silane) and bovine fibronectin were
obtained from Sigma-Aldrich (St. Louis, MO). Penicillin-Streptomycin (10,000 U/mL),
RPMI 1640 (1x, with L-Glutamine and 25 mM HEPES) and PBS were obtained from
Thermo Fisher Scientific (Hampton, NH). Poly(dimethylsiloxane) (Sylgard 184 Silicone
Elastomer) was purchased from Dow Corning, Midland, MI. 200 proof ethanol was
obtained from Decon Laboratories (King of Prussia, PA). Fetal bovine serum was
obtained from Atlanta Biologicals (Flowery Branch, GA). Recombinant GM-CSF was
produced from the B78Hi/GMCSF.1 cell line provided by T. Laufer (University of
Pennsylvania, Philadelphia, PA).

Mice
C57BL/6J mice, WASP-/- mice bred on the C57BL/6J background (26) (both from
Jackson Laboratories), HS1-/- mice bred on the C57BL/6J background (27) and GFPLifeact mice bred on the C57BL/6J background (26) were reared at Children’s Hospital
of Philadelphia. All mice were housed under pathogen-free conditions in the Children’s
Hospital of Philadelphia animal facility. All studies involving animals were reviewed
and approved by the Children’s Hospital of Philadelphia Institutional Animal Care and
Use Committee.

141

Culture of bone marrow derived DCs (BMDCs)
Primary dendritic cells were prepared from murine bone marrow, following the
protocol of Sixt and Lämmermann (28). Bone marrow was flushed from the femurs and
tibiae with sterile PBS. Cells were centrifuged at 1500 rpm for 10 min at 4°C and
resuspended at 2.5 x 106 cells/mL in RPMI 1640 supplemented with 10% heatinactivated fetal bovine serum and 1% penicillin and streptomycin. 1 mL cell suspension
was combined with 9 mL media and 100 μL GM-CSF in a 10 cm Petri dish. On day 3,
10 mL fresh media and 100 μL GM-CSF were added, and on day 6, 100 μL GM-CSF
was added after half of the media was gently replaced. 200 ng/mL LPS was added
between day 7 to 9 and DCs were matured for 24 hours. After maturation, DCs were
centrifuged at 1500 rpm for 10 min at 4°C and resuspended at 100,000 cells/mL for
random migration experiments or 50,000 cells/mL for force measurement experiments.
Cells were maintained at 37°C and 5% CO2.

Surface Preparation for Random Migration Experiments
25 mm round glass coverslips (Thermo Fisher Scientific) were coated with a thin
layer of degassed poly(dimethylsiloxane) (PDMS, 10:1 base to cure by weight) (using a
Laurell spinner (4000 rpm, 1 minute). Coverslips were cured for at least three hours at
65°C. Circular holes were laser cut from the bottom of each well of a 6 well dish. The
PDMS coated coverslips were affixed to the bottom of each well using 10:1 PDMS and
the seal was cured overnight at 65°C. The coverslips were functionalized by
microcontact printing following the protocol of Desai et al (29). Stamps for printing
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were prepared by casting degassed PDMS against a flat silicon wafer. The PDMS was
allowed to cure in contact with the wafer overnight at 65°C. 1 cm2 square stamps were
cut from the block of PDMS using a premade grid pattern as a guide. Stamps were
sonicated in 200 proof ethanol for 5 minutes, rinsed twice in diH2O and gently dried with
N2 gas. 200 μL of a 10 μg/mL solution of fibronectin was added to each stamp and
incubated at room temperature for 2 hours. Stamps were again rinsed twice in diH2O and
gently dried with N2 gas. The 6 well dish containing the PDMS coverslips was treated
for 7 minutes with ultraviolet ozone (UVO Cleaner Model 342, Jelight, Irvine, CA) and
PDMS stamps were used to transfer protein to the coverslip surface. The printed
coverslips were blocked with 0.2 % Pluronic F127 for 1 hour at room temperature, rinsed
twice with sterile PBS and stored at 4°C overnight.
The following day, 1 mL of mature DCs (100,000 cells/mL) were seeded on each printed
coverslip. In inhibition studies, the desired concentration of CK-666 or equivalent
volume of DMSO was added 1 hour prior to imaging and the cells were incubated at
37°C and 5% CO2. Motility was stimulated with 10 nM CCL19 immediately before
moving the plate to the microscope stage.

Live Cell Imaging for Random Migration Experiments
DCs were imaged at 10x by phase microscopy on a Nikon Eclipse TE300 (Nikon,
Melville, NY) with custom-built Labview (National Instruments, Austin, TX) software.
A motorized stage was used to capture images at multiple positions. Time-lapse
experiments were performed by acquiring images every two to three minutes for up to
three hours. Cells were maintained at 37°C and 5% CO2 during imaging.
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Random Motility Data Analysis
Cell migration was analyzed with the Manual Tracking plugin in ImageJ
(http://rsbweb.nih.gov/ij). Cells were tracked over time by manually specifying their
centroid positions in each frame. Cells that were apoptotic or completely stationary were
excluded, as well as any cells in contact with other cells. The list of x- and y-coordinates
obtained from ImageJ was further analyzed with a custom-written MATLAB
(Mathworks, Natick, MA) script. The MATLAB script computed the MSD of the
compiled list of cell tracks and used the Dunn equation 〈
1−

−

〉=2

−

to fit speed (S) and persistence (P) (30). The random motility

coefficient was calculated from the speed and persistence as follows:

=

, where n

specifies the dimensionality (31).

mPAD Preparation
Micropost array detectors (mPADs) were prepared following the protocol of Yang
et al. (32). Micropost arrays were prepared from a silicon master by replica molding.
Negative molds were created by casting degassed PDMS (10:1 base to cure) against a
silanized silicon master mold and curing for 12 minutes at 110°C.

The negative molds

were gently peeled away from the silicon master, plasma treated (SPI Supplies Plasma
Prep II, West Chester, PA) for 7 seconds, and silanized overnight. PDMS (10:1 base to
cure) was added to the negative molds and degassed for 30 minutes to remove any air
bubbles. 25 mm round glass coverslips were cleaned with N2 gas and plasma treated for
90 seconds. The molds were placed, fresh PDMS side down, onto the cleaned coverslip
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and cured at 110°C for 20 hours. The mPADs were gently peeled away from the
negative molds, immediately submerged in 200 proof ethanol and supercritical dried
(SAMDRI-PVT-3D, Tousimis Corporation, Rockville, MD) in liquid CO2. Circular
holes were laser cut from the bottom of one well dishes. mPAD coverslips were secured
to the bottom of the one well dishes with 10:1 PDMS and the seal was cured overnight at
65°C.
10 μg/mL fibronectin was microcontact printed onto the post tips, following the same
procedure as above with minor modifications. After stamping the mPADs, 1 mL of 200
proof ethanol was added and the stamp was gently flicked off the micropost array. The
ethanol was immediately diluted to 60% with diH2O. The mPADs were rinsed three
times with diH2O and were incubated with 1x Δ9-DiI (1,1′-dioleyl-3,3,3′,3′tetramethylindocarbocyanine methanesulfonate; Invitrogen Carlsbad, CA) for one hour,
at room temperature. To prevent photobleaching of the fluorescent label, the mPAD was
covered and lights were dimmed, when possible, for the rest of the preparation process.
The mPADs were gently rinsed three times with diH2O. The post tips were blocked with
0.2 % Pluronic F127 for 1 hour at room temperature, rinsed three times with sterile
diH2O and stored at 4°C overnight. The following day 1 mL of mature DCs (50,000
cells/mL) was seeded on the mPAD. Motility was stimulated with 10 nM CCL19
immediately before moving the dish to the microscope stage, and cells were allowed to
settle on the micropost array before imaging began.
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Live Cell Imaging for Force Measurement Experiments
DCs were imaged at 40x by phase and fluorescence microscopy on a Nikon
Eclipse TE300 with custom-built Labview software. A motorized stage was used to
capture images at multiple positions. Time-lapse experiments were performed by
acquiring images every minute for up to an hour. Cells were maintained at 37°C and 5%
CO2 during imaging.

Traction Force Analysis
A custom MATLAB (Mathworks, Natick, MA) script was used to analyze a series
of paired phase and fluorescent images. Phase images were used to manually delineate
the area occupied by the cell of interest. The corresponding fluorescent image was then
opened and the position of the posts in the area of interest was recorded. The script
determines the ideal position of each post based on the theoretical post packing geometry.
Deflection distance was calculated for the posts in the area of interest as the 2dimensional distance between the ideal position the measured position. The deflections
were then converted into vector forces using Hooke’s law ( =

) and the known spring

constant of the micropost array (k=1.92 nN/μm) for the given post height and diameter.
These forces were then used to calculate the total scalar force per cell, which was
averaged over the entire ensemble of cells for each type of cell (WT, HS1 -/- and WASP -/).
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Statistical Analysis
I used a one way ANOVA along with a Tukey’s Post Hoc Test to determine
statistical significance. Statistically significant differences at p < 0.05 were marked with
an asterisk on plots (*) and statistically significant differences at p < 0.01 were marked
with a double asterisk (**).
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RESULTS
HS1 is Required for Efficient DC Random Migration
It was previously shown that HS1 contributes to DC speed and persistence during
chemotaxis (23), but its role in random migration was not tested. It has been revealed in
a variety of immune cell types that HS1 can have different effects on different modes of
migration (33–37). Therefore, I hypothesized that I would see defects in DC
chemokinesis that were absent during DC chemotaxis. To assess this, I performed
parallel experiments with WT and HS1 -/- DCs undergoing chemokinesis. Briefly, I
plated cells on PDMS surfaces that had been printed with bovine fibronectin and blocked
with the Pluronic F127. I acquired time lapse images of each cell type in phase contrast
and used the Manual Tracking Plugin in ImageJ to quantify cell position as a function of
time.
In these low magnification, phase contrast experiments, the appearance of HS1 -/DCs was qualitatively indistinguishable from that of WT DCs (Figure 5.3). HS1 -/- DCs
were viable and still formed extensive membrane veils and protrusions. However, while
HS1 -/- DCs retained some ability to migrate, the extent of their migration was
significantly reduced. Figure 5.1C and D shows the migration patterns of representative
populations of WT and HS1 -/- DCs. The start position of each cell was set at the origin
to allow for visualization of the distance traveled by all cells in a given field of view. As
expected, both WT and HS1 -/- DCs migrated randomly, with no directional bias. While
both populations of cells were able to migrate, I saw a large difference in the area
explored during migration, with HS1 -/- DCs restricted to a smaller region than WT DCs.
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From this initial observation, it appears that HS1 is an important component of the DC
migratory machinery.
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Figure 5.3. HS1 -/- DCs are morphologically similar to WT DCs. Phase contrast images
of WT DCs
(A) and HS1 -/- DCs (B). Images are snapshots from longer, time course experiments.
Cells are plated on 10 μg/mL fibronectin and are migrating in the presence of 10 nM
CCL19. Scale bar represents 100 μm.
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While some HS1 -/- DCs were able to move, many HS1 -/- DCs appeared to
vacillate around a fixed point. I designated cells as “motile” if they traveled at least two
cell diameters over the course of the experiment. Cells that traveled less than this were
designated as “stationary.” During chemokinesis, 80.45 ± 2.22 % of WT DCs were
“motile,” compared to only 47.61 ± 1.69% for HS1 -/- DCs (Figure 5.1E). This shows
that HS1 -/- DCs have a significant defect in translocation, as compared to their WT
counterparts.
I further quantified the migration of HS1 -/- DCs by calculating the mean squared
displacement (MSD) as a function of time for both WT and HS1 -/- DCs (Figure 5.4A).
When plotting MSD vs. time on a log-log scale, I would expect to see a slope of one for a
population of cells moving randomly or diffusively. This is indeed what I observed for
WT DCs. However, HS1 -/- DCs failed to migrate diffusively over the entire course of
the experiment, as shown by an initial linear rise in MSD followed by a plateau. It has
been shown that HS1 is necessary for the stability of DC lamellipodia (23) and I have
observed dynamic ruffling in my HS1-/- DCs. I hypothesize that the decrease in
migration that I observed at long times could be related to the inability of these cells to
form persistent actin structures.
I next fit the curves for MSD vs. time to the Dunn equation 〈
2

−

1−

−

〉=

(30). This allowed us to calculate a variety of useful

motility metrics, such as average speed (S), persistence length (the distance traveled
before a cell changed direction), persistence time (P, length of time a cell traveled before
changing direction) and random motility coefficient (μ). WT DCs undergoing
chemokinesis moved at speeds of 4.00 ± 0.18 μm/min (Figure 5.4B). HS1 -/- DCs
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showed a significant reduction in migration speed, traveling at only 2.31 ± 0.08 μm/min.
HS1 -/- DCs also showed significant reductions in persistence length, but their persistence
time was unaffected (Figure 4 C and D). This suggests

152

Figure 5.4. HS1 -/- DCs exhibit multiple defects in migration during chemokinesis
(A) MSD vs. time on log-log scale for WT and HS1 -/- DCs. Quantification of DC
random migration: (B) average speed, (C) persistence length, (D) persistence time, (E)
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random motility coefficient. Figures represent average values ± SEM, for > 1000 DCs
from at least three independent experiments per condition. Statistical significance
calculated with single factor ANOVA and post hoc Tukey test. Indicates significant
difference compared to WT DCs. *p<0.05, **p<0.01
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that HS1 -/- DCs were able to turn at the same frequency as WT DCs, but their reduced
speed led to shorter distances traveled between subsequent turns. These effects were
extended to the random motility coefficient (Figure 4E), which is a quantitative measure
of cell diffusivity and is related to speed and persistence as follows:

=

. HS1 -/-

DCs had a much lower random motility coefficient (11.80 ± 1.75 μm2/min) than WT DCs
(38.20 ± 3.41 μm2/min). This agreed with my MSD calculation and confirmed that HS1 /-

DCs were less capable of diffusive migration. From these initial experiments, I

conclude that HS1 expression is required for efficient DC chemokinesis.

HS1 and the Arp2/3 Complex Work Together to Coordinate DC Random Migration
HS1 binds to both the Arp2/3 complex and polymerized actin via its N terminus,
and is thought to stabilize the branched actin network through these interactions (15,20).
I hypothesize that the reduction (but not total elimination) of HS1 -/- DC motility could be
due to the failure of HS1 -/- DCs to stabilize branched actin filaments. To determine
how inhibition of the Arp2/3 complex compares with loss of HS1 function, I incubated
WT DCs with CK-666 (Figure 5A). CK-666 is a small molecule inhibitor that binds to
the Arp2/3 complex and locks it in an inactive conformation, thereby preventing actin
binding and polymerization (38). I tested three different concentrations of CK-666 - 1
μM, 10 μM and 100 μM. WT DCs were added to PDMS surfaces microcontact printed
with fibronectin and were incubated with CK-666 for one hour before imaging. As
predicted, inhibiting Arp2/3 complex function decreased migration, and it did so in a
dose dependent manner. At the highest concentration of CK-666 tested, migration was
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quantitatively indistinguishable from HS1 -/- DC migration, as shown by reductions in
average speed, persistence length and random motility coefficient (Figure 5B-D).
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Figure 5.5. CK666 negatively regulates DC chemokinesis.
(A) Sample images of GFP-Life-act DC inhibited with CK-666, showing GFP-labeled
actin filaments (left) and bright field images of the same cell (right). Scale bar equals 20
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μm. Quantification of WT DC chemokinesis in the presence of CK-666, an Arp2/3
inhibitor (B) average speed, (C) persistence length and (d) random motility coefficient
(WT and HS1 values taken from Figure 5.4 and included for reference). Three different
CK-666 concentrations were used: from left to right 1 μM, 10 μM and 100 μM. Figures
represent average values ± SEM, for > 290 DCs from at least three independent
experiments per condition. Statistical significance calculated with single factor ANOVA
and post hoc Tukey test. Indicates significant difference compared to WT DCs. *p<0.05,
**p<0.01
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Inhibition with CK-666 at any level did not affect the persistence time,
suggesting that the Arp2/3 complex is not required for DCs to change direction at the
proper frequency (data not shown). DMSO exposed cells were used as a control and
showed no significant defects in persistence or random motility (Figure 5.6). To further
explore the importance of the Arp2/3 Complex on DC random migration, I inhibited HS1
-/-

DCs with 100 μM CK-666. Addition of Arp2/3 complex inhibitor to HS1 -/- DCs led

to a reduction in average speed, but the persistence length and random motility
coefficient were not significantly affected (Figure 5.7). Since HS1-/- DC migration is not
greatly affected with addition of Arp2/3 complex inhibitor, this suggests that the defects
observed in HS1-/- migration are partly due to interaction with the Arp2/3 complex.
Next I investigated the role of WASP (Wiskott-Aldrich Syndrome protein),
another Arp 2/3 complex activating protein found in hematopoietic cells (39,40).
Previous studies in DCs have shown that WASP is required for proper morphology and
cytoskeletal organization (23,41,42), antigen processing (43), activation of the innate and
adaptive immune systems (44–46), and migration (23,26,41,47). While various aspects
of WASP -/- DC migration have been studied, to my knowledge no one has yet
determined how WASP impacts the random migration of mature DCs. Since I
hypothesize that defective HS1 -/- DC chemokinesis is due to impaired Arp2/3 complex
activity and branched actin instability, I expected to observe similar defects in WASP -/DC chemokinesis. As I previously observed with HS1 -/- DCs, WASP -/- DCs had
significantly impaired migration, with reduced average speed, persistence length and
random motility coefficient (Figure 5.8, previous HS1 -/- data included as a reference).
The persistence length and random motility coefficient were comparable to the values
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calculated for HS1 -/- DCs. The average speed of WASP -/- DCs (3.07 ± 0.15 μm/min)
was significantly lower than WT DCs (4.01 ± 0.18 μm/min), but was also significantly
higher than HS1 -/- DCs (2.35 ± 0.08 μm/min).
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Figure 5.6. Quantification of WT DC chemokinesis in the presence of DMSO
(A) average speed, (B) persistence length and (C) persistence time, (D) random motility
coefficient. WT values taken from Figure 5.4 and included for reference. Figures
represent average values ± SEM, for > 675 DCs from at least three independent
experiments per condition. Statistical significance calculated with single factor ANOVA
and post hoc Tukey test. Indicates significant difference compared to WT DCs. *p<0.05,
**p<0.01
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Figure 5.7. Quantification of HS1 -/- DC chemokinesis in the presence and absence of
CK-666
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(A) average speed, (B) persistence length and (C) random motility coefficient (WT and
HS1 values taken from Figure 5.4 and included for reference). Figures represent average
values ± SEM, for > 1000 DCs from at least three independent experiments per condition.
Statistical significance calculated with single factor ANOVA and post hoc Tukey test.
Indicates significant difference compared to WT DCs. *p<0.05, **p<0.01
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Figure 5.8. Comparison of chemokinesis of DCs lacking WASP and HS1
(A) average speed, (B) persistence length and (C) random motility coefficient. WASP -/DCs are shown in gray. WT DCs are shown in blue and HS1 -/- DCs are shown in red
(WT and HS1 values taken from Figure 5.4 and included for reference). Figures
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represent average values ± SEM, for > 1000 DCs from at least three independent
experiments per condition. Statistical significance calculated with single factor ANOVA
and post hoc Tukey test. *p<0.05, **p<0.01
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As with HS1 -/- DCs, WASP -/- DCs had no significant reduction in persistence time.
Since HS1 and WASP have similar but non-redundant functions within the cell, it is not
surprising that I observe similar but non-identical results after their knockout.

HS1 is Required for Maximal Dendritic Cell Force Generation
Previous work from my group has shown that inhibition of actin polymerization
results in a drastic reduction in magnitude of DC traction forces (48). In that study, I
used a nonspecific actin polymerization inhibitor, and it is unknown how individual
actin-binding proteins are involved in DC force production. In the present study, I
wanted to determine whether HS1 is involved in force generation. In the preceding
sections, I have highlighted the impact of HS1 on the kinematics of DC migration. Since
cell migration and force generation are intimately linked processes, I expected the impact
of HS1 on random migration to correlate with a reduction in traction force strength (49).
I also posited that a defect in HS1 -/- DC force generation would be a direct result of its
interaction with the Arp2/3 complex, and would therefore extend to other proteins
interacting with the Arp2/3 complex, such as WASP.
To test this hypothesis, I used micropost array detectors (mPADs) to measure the forces
exerted by WT, HS1 -/- and WASP -/- DCs during chemokinesis. mPADs are arrays of
elastic micropillars which are sensitive enough to measure the weak forces exerted by
DCs and other amoeboid cell types (50). I used a 10:1 solution of PDMS to replica mold
mPADs from silicon master molds. Before adding cells to the mPADs, I stamped the
post tips with bovine fibronectin, and stained them with a lipophilic dye in order to
visualize post deflection. The mPADs were also blocked with Pluronic F127 to ensure
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that the cells were interacting with the post tips and not with the sides of the posts or
interpost regions. I added DCs to the mPADs at a concentration of 50,000 cells/mL
along with 10 nM CCL19, and allowed the cells to settle on the posts before imaging. A
series of fluorescence and phase images were captured in order to record post deflections
and cell position over time. A representative cell imaged in phase and fluorescence is
shown in Figure 5.9A and B. The arrow in Figure 5.9B points to the location of the cell,
where post deflections were observed and quantified.
Individual traction forces were calculated using a custom MATLAB code that
converted post deflections into vector forces using Hooke’s law, given the spring
constant for the array (1.92 nN/μm). I then calculated the total force per cell, as the sum
of all the scalar forces exerted on the posts by a given DC. Since there was considerable
variation within each population of cells, I chose to compute an ensemble average as a
function of time (Figure 5.9C). WT DCs produced traction forces on the order of 10
nN/cell, which agrees well with my previous measurements (48). I saw an initial rise in
WT traction forces, followed by a plateau. I hypothesize that this initial rise in force is
due to imaging shortly after adding the cells, before they had a chance to fully engage the
post array. Both WASP -/- DCs and HS1 -/- DCs are capable of interacting with the
mPAD array, but their force generation appeared to be lower than what I observed in WT
cells.
I next performed a time and ensemble average for all three populations of DCs
(Figure 5.9D). Compared to WT DCs, WASP -/- and HS1 -/- DCs produced significantly
less force per cell. WT DCs produced an average force of 13.76 ± 0.84 nN/cell, whereas
WASP -/- DCs produced an average force of 9.55 ± 0.69 nN/cell and HS1 -/- DCs
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produced an average force of 3.96 ± 0.40 nN/cell. The force generation was most
affected in HS1 -/- DCs, whose forces were more than 3 times lower than WT forces.
While WASP -/- DCs produced significantly less force than WT DCs, they produced
significantly greater force than HS1 -/- DCs. These results show
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Figure 5.9. Calculation of DC traction forces using mPADs.
(A) Phase contrast image of DC on mPAD surface. Scale bar equals 20 μm. Fluorescent
and phase images correspond to same cell and same position. (B) Sample image of
fluorescent micropost tips in area occupied by DC. Post diameter and height are 1.83 μm
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and 12.9 μm, respectively. (C). Average traction forces for ensemble of WT DCs, HS1 -/DCs and WASP -/- DCs. The forces were calculated from images such as those shown in
(A) and (B). Displacement of mPADs was converted to traction force using Hooke’s law
and known spring constant (1.92 nN/μm) for the mPAD array. The x-axis indicates time
in minutes, with 0 corresponding to the start of imaging. Lines indicate 3 point moving
averages for each condition. (D) Time and ensemble averages of DC traction forces,
corresponding to values shown in (C). Figures represent average values ± SEM, for at
least 28 DCs per condition. Statistical significance calculated with single factor ANOVA
and post hoc Tukey test. Indicates significant difference compared to WT DCs. *p<0.05,
**p<0.01
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that both WASP and HS1 are involved in the DC force transduction pathway, but that
HS1 is more important for force generation than WASP.
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DISCUSSION
Due to the importance of DC migration and the involvement of the actin
cytoskeleton in this process (8), I sought to identify whether the actin regulatory protein
HS1 is required for DC random migration and force generation. I used microcontact
printed PDMS coverslips to assess random migration and mPADs to measure cellular
traction forces. I found that HS1 contributed to random migration through its effect on
speed but not persistence time. HS1 -/- DCs migrate more slowly, and often fail to
translocate over a 3 hour period, leading to a reduction in area explored during migration.
One of the ways that HS1 interacts with actin is through activation of the Arp2/3
complex. This interaction appears to be important in DCs, as inhibition of the Arp2/3
complex in WT DCs or elimination of other Arp2/3 complex nucleating proteins led to
similar reductions in migration. Migration and force generation are often intimately
linked and I observed a concomitant reduction in force generation in HS1 -/- DCs along
with defects in migration. Interestingly, while migration seems to have a general
dependence on the Arp2/3 complex, force generation is affected to a different degree by
different Arp2/3 complex activators. Since DCs need to migrate quickly and efficiently
to the lymph nodes to launch an adaptive immune response (7), it is possible that defects
in the Arp2/3 complex, HS1 or other similar proteins could lead to immune
dysregulation. This is indeed the case for mutated WASP, which leads to the X-linked
autoimmune disease Wiskott-Aldrich syndrome (WAS) (38,39). WAS leads to complete
immune system dysregulation (reviewed in (40)) and is characterized by
thrombocytopenia, easy bruising, frequent and prolonged bleeding, eczema and recurrent
infections (41). To date, abnormalities in HS1 have been associated with both chronic
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lymphocytic leukemia (51) and systemic lupus erythematosus, (52) and it is possible that
HS1 will be linked to more diseases in the future.
Two parameters that describe DC random migration are cell speed and cell
persistence. In DCs, I saw that HS1 does not affect the persistence time, or frequency of
turning. It does, however, contribute a great deal to the speed of migration. HS1 is the
hematopoietic homologue of the more widely studied NPF cortactin (19). Many of the
migration results that I observe in

HS1 -/- DCs mirror what is seen in cells expressing

reduced levels of cortactin (53). Cortactin, unlike WASP or other NPFs, has the unique
ability to stabilize actin branch points and prevent disassembly (54,55). I hypothesize
that this stabilizing effect is responsible for the reduction in speed I observe in HS1 -/DCs. WASP is still present in these cells, allowing Arp2/3 complex branch points to
form, but without HS1 holding the branch point together, the structure disassembles too
quickly for a cell to gain much speed.
I saw that HS1 and WASP play a role in DC random migration to different
degrees. One of the first differences I observed was the extent of reduction in average
speed for each type of cell. Both HS1 and WASP -/- DCs move more slowly, but WASP /-

DCs were significantly faster than HS1 -/- DCs. These disparate results could be

explained by differences between the two proteins. WASP is a class I NPF, with a VCA
domain that binds to monomeric actin and the Arp2/3 complex, while HS1 is a class II
NPF with an NTA domain that binds to polymerized F actin and the Arp2/3 complex
(24). Class I NPFs like WASP are thought to initiate Arp2/3 complex-mediated actin
polymerization by bringing monomeric G-actin in close proximity to the Arp2/3
complex, while Class II NPFs like HS1 are thought stabilize a pre-formed branch point
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by binding to both F-actin and the Arp2/3 complex. There are multiple class I NPFs in
hematopoietic cells, but HS1 is the only known Class II NPF. Perhaps the speed is not
affected as much in WASP -/- DCs due to Class I NPF redundancy, whereas elimination
of HS1 rids the cell of all stabilizing Class II NPFs. Another possibility could be related
to differences in downstream binding partners of the two proteins.
I expected to see similar force reductions in WASP and HS1 -/- DCs, since they
are both known to play a role in adhesive structures, such as podosomes (23).
Furthermore, the Arp2/3 complex, which is activated by both HS1 and WASP, has been
shown to transiently associate with vinculin in focal complex like structures (49).
Interestingly, I saw much smaller forces in HS1 -/- DCs than in WASP -/- DCs. This
difference could again be explained by the slight differences in function of the two
proteins. Since HS1 -/- DCs have unstable branched actin networks, it is possible that
their actin networks disassemble before they are able to generate substantial force. It has
also been shown that reducing levels of cortactin inhibits the assembly of adhesion
structures (53), whereas loss of WASP -/- seemingly has no effect on integrin organization
(6). Therefore, it is possible that adhesion and force generation are influenced by Class II
NPFs (i.e. HS1) more strongly than they are by Class I NPFs (i.e. WASP).
In this study, I used CK-666 to identify whether the migration effects seen in HS1 -/- DCs
were due to HS1's ability to activate and stabilize Arp2/3 complex mediated actin
polymerization. CK-666 is a potent inhibitor of the Arp2/3 complex, with an IC50 of 17
μM and 4 μM, for bovine and human Arp2/3 complex, respectively (56). I chose a range
of concentrations surrounding these IC50 values (1 μM, 10 μM and 100 μM), since I
expected the IC50 for murine Arp2/3 complex to lie somewhere in this range. Previous
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cytotoxicity studies have indicated that concentrations up to 200 μM CK-666 with
incubation times similar to ours did not negatively impact cell viability (57). I saw a
graded decrease in migration as more CK-666 was added to DCs, with the highest
concentration (100 μM) approximating the behavior of HS1 -/- DCs. I still saw low levels
of migration, even at high levels of inhibitor, which is likely due to incomplete inhibition
of cellular Arp2/3 complex. While the speed of HS1 -/- DCs is further decreased upon
Arp2/3 complex inhibition, the persistence length and random motility coefficient are
unaffected. Removing HS1 from DCs greatly reduces Arp2/3 complex activity without
completely eliminating its ability to polymerize actin. When inhibitor is added, the
remaining Arp2/3 complex activity is further reduced.
In combination with previous studies, this work reveals that HS1 is involved in
various aspects of DC migration. Klos Dehring et al. showed that during chemotaxis,
DCs lacking HS1 form highly dynamic lamellipodia, move well through transwells and
travel through microfluidic devices with lower directionality and higher speed (23). This
description of overly dynamic, unstable lamellipodia agrees well with my observations
that HS1 -/- DCs form extensive membrane ruffles during chemokinesis and are often
observed to quickly vacillate around fixed points. This suggests that new branched actin
structures are actively being formed, but due to the loss of HS1, and the resultant
instability of the actin network, they are often too inefficient to allow for DC
translocation. During chemotaxis, HS1 -/- DCs are less able to migrate persistently up a
gradient than WT DCs (23). Since chemokine receptor expression is unaltered by HS1
removal, and endpoint studies of HS1 -/- DCs show that they are able to properly respond
to a gradient (transwell), this defect in directional persistence is likely due to instability
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and not chemokine responsiveness (23). It is possible that HS1 -/- DCs, are unable to
maintain protrusive actin structures at the front of the cell while traveling up a gradient.
Dynamic lamellipodial protrusions at other areas of the cell body may lead to deviations
in directionality. These deviations would then be corrected upon additional chemokine
signaling, but the inherent actin instability would lead to more frequent missteps and
lower observed persistence in HS1 -/- DCs. In my chemokinesis experiments, I observed
no significant differences in persistence time. While this may seem contradictory, DCs
behave quite differently in chemokinesis and chemotaxis. In chemokinesis, DC motion is
completely random, whereas in chemotaxis, DCs are guided in a specific direction. Klos
Dehring et al. showed that DCs seemed to have a higher propensity for deviations from
directed migration, and in essence moved more randomly than their WT counterparts
(23). Therefore, it is quite possible that in a scenario where DCs are being encouraged to
migrate randomly, HS1-/- DCs will do so as efficiently as WT DCs.
Another major difference between my study and the work of Klos Dehring et al.
is the effect of HS1 on cell speed. Klos Dehring et al observe a significant increase in
speed during chemotaxis (23), while I observed a significant decrease during
chemokinesis. While it is clear that HS1-/- DCs migrate towards a chemokine gradient
during chemotaxis, the spread of HS1-/- DC trajectories is not identical to the spread of
WT DCs trajectories (23). The cell tracks for WT DCs traveling towards a gradient in
the y-direction are symmetric about the y-axis (23). However, the cell tracks for HS1-/DCs traveling towards a gradient in the y-direction are biased towards the positive xdirection (23). The directional bias seen in HS1-/- DCs could be due to an increased
susceptibility to flow in the microfluidic gradient generator. Therefore, it is possible that
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the increase in HS1-/- DC speed during chemotaxis is due the cells being more easily
pushed along by flow in the system. This is quite likely given the effect of HS1 on DC
adhesive strength (defective podosomes in immature HS1-/- DCs (23) and significantly
reduced traction forces in mature HS1-/- DCs). In the present study, I observed a
significant decrease in speed, in an environment free of flow and directional cues.
Therefore, it is possible that innate, random migratory speed is impaired in HS1-/- DCs
when they are not presented with any additional stimuli, but that reductions in adhesion
and subsequent susceptibility to flow could help DCs to compensate for defects in speed
during chemotaxis.
While I found the Arp2/3 complex to be important for DC random migration on
2D surfaces, it appears to be dispensable for other forms of migration. Recently Vargas
et al. showed that Arp2/3 complex inhibition had no effect on DC chemotaxis in
confinement (58). DCs in confined channels did not form leading edge branched actin
networks but instead had extensive actin cables at the cell rear. This finding does not
negate my findings, since many of the experimental variables were different between
their study and ours. Rather, this suggests that DCs can employ multiple methods of
migration based on the characteristics of their microenvironment.
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CHAPTER 6 : CONCLUSIONS AND FUTURE
WORK

189

SPECIFIC AIMS
The research presented in this thesis shows that I was able to characterize DC
chemokinesis on PDMS surfaces and identify several key biophysical and biomolecular
factors that regulate this process. The specific aims of this work were as follows:

Aim 1: Quantify DC chemokinesis on PDMS-coated coverslips and mPADs

Aim 2: Identify biophysical factors involved in regulating DC chemokinesis

Aim 3: Identify biomolecular factors required for efficient DC random migration
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SPECIFIC FINDINGS
DC Chemokinesis on PDMS Surfaces
In Chapter 3, I thoroughly characterized DC random migration on PDMS-coated
coverslips through calculation of the MSD, average speed, persistence time, persistence
length and random motility coefficient. While the speed of DCs has been characterized
on a variety of surfaces (1–3), the other parameters have only recently been measured (4).
This is the first measurement of these values on PDMS-coated surfaces and my
observations support the use of PDMS surfaces for the study of DC migration. Since
many cell types behave differently on different surfaces (5), and past DC chemokinesis
experiments were performed on glass (4), this work provides an important baseline for
unperturbed DC chemokinesis on my engineered substrates. I found that fibronectin
provides a good ECM protein for anchoring DCs to the substrate and that the protein
could be readily transferred through microcontact printing. DC chemokinesis was stable
across a variety of fibronectin and chemokine concentrations. My values for average
speed agree well with other measurements in the literature, suggesting cellular speed is a
very robust property of DC migration (2,6). Furthermore, my values for speed and
persistence are inversely correlated and fit a well-established trend seen in a variety of
cell types undergoing chemokinesis (7). Finally, I used mPADs to calculate traction
forces of randomly migrating DCs. Previous DC force measurements were performed
during chemotaxis, and this work provides the first in-depth analysis of the forces of
random motility. Collectively these experiments provide a complete biomechanical
description of DC chemokinesis
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Biophysical Components of DC Chemokinesis
Up to this point, I have used two different substrates—PDMS-coated coverslips
for quantification of random motility parameters and mPADs for traction force
measurements. These two surfaces are quite different from one another in terms of both
stiffness and geometry. It has been shown that the physical properties of the extracellular
environment can affect a variety of cell properties (5). Of particular interest, it has been
shown in other immune cells that stiffness and geometry can greatly impact cell
migration (8–11). This topic had not been addressed in DCs and was the focus of the
study described in Chapter 4. I began by asking ourselves how DC migration differed on
the two surfaces (PDMS-coated coverslips and mPADs). I ran motility assays on mPADs
instead of PDMS-coated coverslips and observed significant differences in migration. I
next engineered multiple substrates to independently investigate the effects of stiffness
and geometry on DC random migration. First, I used a series of different mPADs with
different stiffnesses and identical 2D geometry and determined that DCs are insensitive to
substrate stiffness. This also suggested to us that DC migration was influenced by
geometry. To test this directly, I held stiffness constant while varying geometry of
printed ligand on PDMS-coated coverslips. These experiments revealed that DC
migration was nearly identical on patterned PDMS-coated coverslips and mPADs and
confirmed my hypothesis that DC chemokinesis is regulated by substrate geometry.
After these initial experiments, I performed a variety of small molecule inhibitor studies
to identify the signaling pathways involved in geometry sensing. I identified three key
pathways—organization of the actin cytoskeleton, myosin contractility and integrin
engagement. Through this work, I provide the first description of how DCs respond to
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environmental stiffness and geometry and highlight some of the key cell signaling
molecules involved in this process.

Biomolecular Components of DC Chemokinesis
In Chapter 5, I investigated the specific contributions of two actin regulatory
proteins to DC chemokinesis. It has long been understood that polarization of a cell’s
cytoskeleton is a crucial first step in locomotion (12). Two proteins involved in
organization of actin at the leading edge are HS1 and WASP, which act with the Arp 2/3
complex to form branched actin networks (13).

I quantified random motility of DCs

lacking each of these proteins individually and determined that they are both critical for
regulating cellular speed but had no effect on persistence. It seems likely to us that their
influence on migration is mediated through their interaction with the Arp2/3 complex, as
direct inhibition of this protein complex yielded similar defects in motility. While the
importance of WASP in DCs has been clearly established, only two studies of HS1
deficient DCs exist (14–17). This study provides the first insight into how HS1 is
involved in DC chemokinesis and complements previous findings of how WASP
influences DC migration. I further characterized the random migration of HS1 -/- and
WASP -/- DCs through quantification of traction forces. I found that both proteins
contribute to the strength of DC interactions with their surroundings, but that HS1 is
much more critical for this process than WASP. These are the first traction force
measurements reported for HS1 and WASP deficient DCs. Overall, these experiments
provide considerable insight into how DCs organize their cytoskeletal machinery and
interact with their surroundings as they migrate.
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FUTURE WORK
Filopodial Control of Environmental Sensing and Directional Commitment
A striking feature of dendritic cells is the intricate network of filopodial
extensions at the cell periphery (Figure 6.1). Several studies have been performed to
identify the importance of these structures in DCs, and it is widely accepted that they are
involved in exploring the cell’s environment. For example, filopodia seem to assist DCs
in the lymph node as they search for cognate T cells, improving the ability of DCs to
probe the surrounding cells and providing increased surface area for the formation of
cell-cell contacts (18,19). It has also been shown in other cell types that filopodia interact
with chemical and topographical signals in the microenvironment (20,21). My
observations of migrating DCs seem to indicate that filopodia preferentially form at the
front of the cell, but it has not been firmly established whether these structures are
actively involved in DC directional decision making. Answering this question would
greatly enhance my understanding of DC migration, particularly how DCs reorganize
their migration machinery and make decisions about where they would like to go. I
propose acquiring long time courses of migrating GFP-Lifeact DCs and computing a
correlation coefficient for direction of motion and filopodial positions. If a correlation
does exist, one could develop a model for predicting DC migration based on filopodial
distribution. Another interesting component of this study would be determining the force
profile of filopodia. In other cell types, it has been shown that adhesive structures exist
along the base of filopodia (22). I have previously shown that the strongest traction
forces in DCs during chemotaxis are concentrated at the leading edge (23). It would be
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interesting to spatially resolve the force distribution at the leading edge to determine if
these strong pulling forces occur under the cell body or the filopodia.
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Figure 6.1. DCs form numerous filopodia that extend from the plasma membrane
Mature GFP-Lifeact DC. Scale bar equals 20 μm.
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Understanding the Biomechanics of Cell Turning
Another interesting topic for future study would be understanding how DCs turn.
While movement up a chemoattractant gradient plays an important role in DC function,
DCs must also be able to reassess their surroundings and change direction. This process
of changing directions or turning is quite physiologically relevant. For example, before
DCs commit to a specific direction, they often dance around between two adjacent
lymphatic vessels (24). This concept has also been recapitulated in vitro by studying
competing chemokine gradients (3,25). Another example is random migration in the
lymph nodes, in which DCs are constantly changing direction in their search for cognate
T cells (19,26). Although the ability to change directions is important, the exact
mechanisms through which DCs turn are unclear. While this is an interesting problem, it
is technically challenging. A previous study by Liu et al. used a microfluidic approach to
examine turning dynamics in a neutrophil-like cell line (27). One could use this approach
with DCs, but they are weakly adherent and are subject to drift in the presence of even
small amounts of flow. Therefore, I believe this experiment would be best carried out in
a flow free environment. From these experiments one could determine how long it takes
DCs to respond to a reversal in stimulus and the path a DC takes as it turns. One could
imagine two possible scenarios for how a cell might turn. It could stop in its tracks and
flip the front and rear with no actual displacement, or its front could remain its front the
entire time as the whole cell follows a circuitous path to realign in the direction of
attractant. Another component of this study would be determining the force distribution
of a turning DC, which may shed some light on the internal reorganization that is
occurring. The results discussed in Chapter 4 may be of some use for a study in cell
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turning. Adding pattered surfaces (either mPADs or printed islands) would give the cells
a stimulus for turning. The hierarchy between soluble chemoattractant and ligand
patterning is unknown, and could also be an interesting avenue to explore.

Quantifying Adhesive Strength and Organization of Podosomes on mPADs
In all of the work discussed in this thesis I described the migration and force
generation of mature DCs. I chose to use mature DCs because they are known to be more
motile (28). While immature DCs are less motile, they do possess an interesting actin
structure (the podosome), which is absent from mature DCs (29). Podosomes are
composed of an actin rich core surrounded by a ring of adhesion molecules (30). The
exact function of podosomes in DCs is not clear, but it has been suggested that they may
play a role in adhesion, migration and mechanosensing (30,31). Because immature DCs
contain these structures and mature DCs do not, I would expect the force profiles to be
quite different depending on the maturation state of the DC. Ideally one would isolate the
force per podosome, but depending on their distribution, it may be difficult to resolve
using the standard DC force measurement setup (1.83 μm post diameter, 3 μm spacing).
If resolution becomes an issue, I propose using the smaller diameter mPADs (800 nm
diameter, 2 μm spacing). In Chapter 4 I showed that there were no differences in DC
migration between these two mPADs. The effective spring constant of the two mPADs is
also quite similar, so the compliance of either should be well suited to DC force
measurement. Another interesting aspect of this study would be examining the actin
structures in immature DCs on microposts. When mature DCs engage the microposts, I
see the formation of artificial actin ring structures. These rings are unlike podosomes,
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and are not found in mature DCs on continuous, printed surfaces. I hypothesize that
these actin rings are involved in mechanosensing. However, in immature DCs, which
already possess mechanosensing machinery in the form of podosome arrays, it is
unknown how the cell’s actin cytoskeleton will respond to the mPAD. It is possible that
no rings will form, if the podosomes are sufficient for mechanosensing. It is also
possible that podosomes will be replaced with these actin rings or some hybrid structure
will be formed.
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FINAL THOUGHTS
Without dendritic cells, my immune systems would be in complete disarray. The
importance of DCs in fighting disease and infection has led to their use in a variety of
clinical trials as well as an FDA approved vaccine. Migration is essential for the function
of DCs, and improper trafficking of DCs manifests itself in severe autoimmunity and an
inability to fight off disease. As such, characterizing all aspects of DC migration is
crucial to improving my understanding of immunity and perfecting future treatments. In
this thesis, I build upon existing knowledge through the use of PDMS surfaces to
characterize random migration and identify several key biomolecular and biophysical
parameters. I hope that this work will motivate future scientists to continue uncovering
new information about this complex and exciting cell type.
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